###begin article-title 0
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
###xml 106 113 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn2">&#9830;</xref>
An Unconventional Diacylglycerol Kinase That Regulates Phospholipid Synthesis and Nuclear Membrane Growth*diamond
###end article-title 0
###begin p 1
Both authors contributed equally to this work.
###end p 1
###begin p 2
###xml 199 214 199 214 <email xmlns:xlink="http://www.w3.org/1999/xlink">ss560@cam.ac.uk</email>
 To whom correspondence should be addressed: Cambridge Inst. for Medical Research, University of Cambridge, Wellcome Trust/MRC Bldg., Hills Rd., CB2 0XY Cambridge, UK. Tel.: 44-1223-762-641; E-mail: ss560@cam.ac.uk. 
###end p 2
###begin p 3
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 3
###begin p 4
 applies to Author Choice Articles
###end p 4
###begin p 5
###xml 485 489 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 602 606 602 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 635 639 635 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 719 723 719 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 977 981 977 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 313 318 <span type="species:ncbi:4932">yeast</span>
Changes in nuclear size and shape during the cell cycle or during development require coordinated nuclear membrane remodeling, but the underlying molecular events are largely unknown. We have shown previously that the activity of the conserved phosphatidate phosphatase Pah1p/Smp2p regulates nuclear structure in yeast by controlling phospholipid synthesis and membrane biogenesis at the nuclear envelope. Two screens for novel regulators of phosphatidate led to the identification of DGK1. We show that Dgk1p is a unique diacylglycerol kinase that uses CTP, instead of ATP, to generate phosphatidate. DGK1 counteracts the activity of PAH1 at the nuclear envelope by controlling phosphatidate levels. Overexpression of DGK1 causes the appearance of phosphatidate-enriched membranes around the nucleus and leads to its expansion, without proliferating the cortical endoplasmic reticulum membrane. Mutations that decrease phosphatidate levels decrease nuclear membrane growth in pah1Delta cells. We propose that phosphatidate metabolism is a critical factor determining nuclear structure by regulating nuclear membrane biogenesis.
###end p 5
###begin p 6
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 6
###begin p 7
###xml 49 78 49 78 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">National Institutes of Health</grant-sponsor>
###xml 85 93 85 93 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">GM-28140</grant-num>
###xml 103 138 103 138 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">United States Public Health Service</grant-sponsor>
###xml 188 260 188 260 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Wellcome Trust Career Development Fellowship in Basic Biomedical Science</grant-sponsor>
###xml 413 426 413 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">advertisement</italic>
This work was supported, in whole or in part, by National Institutes of Health Grant GM-28140 from the United States Public Health Service (to G. M. C.). This work was also supported by a Wellcome Trust Career Development Fellowship in Basic Biomedical Science (to S. S). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 7
###begin p 8
This article was selected as a Paper of the Week.
###end p 8
###begin p 9
###xml 99 100 99 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 423 424 423 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn4">3</xref>
###xml 458 459 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 512 513 512 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
Phospholipids are the major cellular components required for the assembly of biological membranes (1). The regulated production and distribution of phospholipids during the cell cycle or during development often underlie striking changes in membrane biogenesis, which, in turn, can impact on the size, shape, or number of organelles. For example, stimulation of phospholipid biosynthesis accompanies the expansion of the ER3 in professional secretory cells (2) or neurite growth during neuronal differentiation (3). Despite these interesting observations, the molecular mechanisms responsible for coupling lipid production to organelle morphology remain largely unknown.
###end p 9
###begin p 10
###xml 225 226 225 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 558 559 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 693 694 693 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 1116 1117 1116 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 1363 1364 1363 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 407 412 <span type="species:ncbi:4932">yeast</span>
An organelle that undergoes striking structural changes during the cell cycle is the nucleus. The nucleus is delimited by the nuclear envelope, which consists of a double lipid bilayer, the outer and inner nuclear membranes (4). The outer membrane is continuous with the ER, whereas the inner membrane faces the nucleoplasm and binds to chromatin. Nuclear membrane growth is essential for cell division. In yeast, nuclear membrane expansion allows anaphase to take place within a single nuclear compartment that partitions between mother and daughter cells (5). In metazoan cells, the nuclear membrane expands at the end of mitosis to accommodate chromatin decondensation and DNA replication (6). The source of the nuclear membrane and the mechanism by which it is added to the nuclear envelope remain unknown. Nuclear envelope remodeling is also important for cell types that undergo dramatic nuclear structure changes during their differentiation, such as mammalian blood cell types, where nuclei can be highly lobed and segmented, or spermatocytes and myocytes, where nuclei can take very elongated morphologies (7). The importance of proper nuclear envelope structure in cell physiology is underscored by the recent identification of several diseases that are associated with changes in nuclear shape and are caused by mutations in nuclear envelope proteins (8).
###end p 10
###begin p 11
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 680 684 680 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 697 699 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
We have recently identified an unexpected link between phospholipid biosynthesis and nuclear structure. Mutations in Pah1p, a PA phosphatase that catalyzes the dephosphorylation of PA to DAG (9), cause proliferation of the nuclear/ER membrane and a massive expansion of the nucleus (10). Interestingly, the activity of Pah1p is regulated by Cdc28p-dependent phosphorylation during mitosis. A phosphorylation-null Pah1p mutant has higher PA phosphatase activity than the wild-type enzyme (11). Consistent with this, cells lacking Nem1p-Spo7p, the phosphatase complex that dephosphorylates Pah1p, accumulate hyperphosphorylated Pah1p and exhibit nuclear membrane proliferation like pah1Delta cells (10).
###end p 11
###begin p 12
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 287 291 287 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 374 376 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 506 508 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 707 708 703 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 701 708 697 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 754 758 750 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 821 822 817 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 824 826 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 102 107 <span type="species:ncbi:4932">yeast</span>
There are two key consequences of the changes in PA levels that take place in pah1 mutants. First, in yeast cells, PA regulates coordinately the transcription of many phospholipid biosynthetic enzyme genes through the PA-sensitive repressor Opi1p (12). When levels of PA are high, as in pah1Delta cells, Opi1p is excluded from the nucleus, and transcription is derepressed (13). Interestingly, Pah1p regulates the transcription of these genes through both Opi1p-dependent and Opi1p-independent mechanisms (11). Second, both PA and DAG are the precursors for the synthesis of abundant phospholipids that are used for membrane biogenesis, through the CDP-DAG and CDP-choline pathways, respectively (see Fig. 1A). Therefore, changes in PA and DAG levels in pah1 mutants impact on the cellular levels of these phospholipids (9, 14).
###end p 12
###begin p 13
###xml 363 367 363 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 380 382 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 384 386 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 1003 1007 999 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 1029 1033 1025 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HSD1</italic>
###xml 1218 1219 1214 1215 <underline xmlns:xlink="http://www.w3.org/1999/xlink">D</underline>
###xml 1220 1221 1216 1217 <underline xmlns:xlink="http://www.w3.org/1999/xlink">G</underline>
###xml 1221 1222 1217 1218 <underline xmlns:xlink="http://www.w3.org/1999/xlink">k</underline>
###xml 1414 1418 1410 1414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
How the inactivation of Pah1p leads to nuclear growth is not understood. Moreover, whether Pah1p regulates primarily ER or nuclear membrane biogenesis and whether particular lipids are associated with these changes are not known. We have shown previously that the up-regulation of phospholipid synthesis is necessary but not sufficient to drive nuclear growth in pah1Delta cells (10, 11). Therefore, there could be additional factors required for nuclear expansion. To investigate the role of phospholipid biosynthesis in nuclear membrane formation and to identify novel components involved in this process, we applied two complementary genetic approaches. First, a systematic search among mutants of known phospholipid biosynthetic enzymes revealed that only Pah1p affects nuclear structure. We therefore performed two non-biased screens looking for previously uncharacterized genes that could encode PA regulators and examined their effect on nuclear structure. Both screens identified the same gene, DGK1 (known previously as HSD1), encoding a nuclear/ER integral membrane protein. We show that Dgk1p counteracts the effects of Pah1p at the nuclear membrane by controlling PA levels. Dgk1p is a novel CTP-dependent DAGkinase that catalyzes the phosphorylation of DAG to PA. Unlike previously described DAG kinases that use ATP, Dgk1p utilizes CTP as a phosphate donor for the kinase reaction. Overexpression of DGK1 causes recruitment of PA reporter protein on the nuclear membrane and leads to its expansion. Interestingly, cortical ER membrane is not proliferating in these cells. These data reveal a specific role for PA metabolism in nuclear membrane biogenesis.
###end p 13
###begin title 14
EXPERIMENTAL PROCEDURES
###end title 14
###begin p 15
###xml 0 43 0 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Yeast Strains, Media, and Growth Conditions</italic>
###xml 95 102 95 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 159 165 159 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 312 316 312 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 318 322 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HIS3</italic>
###xml 403 407 403 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 409 413 409 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRP1</italic>
###xml 444 448 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 457 461 453 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 467 471 459 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 525 547 513 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAT1, GAT2, PSD1, CHO2</italic>
###xml 553 557 541 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OPI3</italic>
###xml 568 572 556 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 626 632 610 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KanMX4</italic>
###xml 650 654 634 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 656 660 640 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRP1</italic>
###xml 695 699 679 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 713 717 697 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 1015 1019 999 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 1020 1022 1004 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10</italic>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 48 53 <span type="species:ncbi:4932">yeast</span>
###xml 832 837 <span type="species:ncbi:4932">Yeast</span>
###xml 867 872 <span type="species:ncbi:4932">yeast</span>
###xml 1231 1236 <span type="species:ncbi:4932">yeast</span>
###xml 1307 1312 <span type="species:ncbi:4932">yeast</span>
Yeast Strains, Media, and Growth Conditions-The yeast strains used in this study are listed in Table 1. Unless stated otherwise, the deletion mutants shown in Fig. 1 were obtained from Open Biosystems and are derived from the BY4742 strain. Knock-out of DGK1 was done by homologous recombination, transforming a dgk1::HIS3 fragment containing 5'- and 3'-flanking sequences into the wild-type (RS453) or pah1::TRP1 deletion strain to obtain the dgk1Delta or pah1Delta dgk1Delta strains, respectively. Deletion of other genes (GAT1, GAT2, PSD1, CHO2, and OPI3) into the pah1Delta strain was done by transforming the appropriate KanMX4 fragments into a pah1::TRP1 strain complemented by a YCplac33-PAH1 plasmid. The PAH1 plasmid was then shuffled out on 5-fluoroorotic acid-containing plates to yield the appropriate double deletions. Yeast cells were grown in YEPD (1% yeast extract, 2% peptone, and 2% glucose) or synthetic medium containing 2% glucose and lacking the appropriate amino acids for plasmid selection. GAL1/10-dependent overexpression was performed by changing the carbon source of early log phase cells from 2% raffinose to 2% galactose. Cells were grown at 30 degreesC unless mentioned otherwise. To assay growth of yeast cells in medium lacking inositol, synthetic medium was prepared using yeast nitrogen base lacking inositol (Bio 101, Inc.).
###end p 15
###begin p 16
###xml 0 7 0 7 <label xmlns:xlink="http://www.w3.org/1999/xlink">TABLE 1</label>
###xml 7 39 7 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Yeast strains used in this study</bold>
###xml 7 39 7 39 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="17"><bold>Yeast strains used in this study</bold></p>
###xml 7 39 7 39 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="17"><bold>Yeast strains used in this study</bold></p></caption>
###xml 39 45 39 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Strain</bold>
###xml 39 45 39 45 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"><bold>Strain</bold></th>
###xml 45 53 45 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Genotype</bold>
###xml 45 53 45 53 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><bold>Genotype</bold></th>
###xml 53 64 53 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ref./source</bold>
###xml 53 64 53 64 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><bold>Ref./source</bold></th>
###xml 39 64 39 64 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th colspan="1" rowspan="1" align="left" valign="bottom"><bold>Strain</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Genotype</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Ref./source</bold></th></tr>
###xml 39 64 39 64 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th colspan="1" rowspan="1" align="left" valign="bottom"><bold>Strain</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Genotype</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Ref./source</bold></th></tr></thead>
###xml 64 71 64 71 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> RS453 </td>
###xml 71 74 71 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAT</italic>
###xml 74 75 74 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 75 118 75 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade2-1 his3-11,15 ura3-52 leu2-3,112 trp1-1</italic>
###xml 71 118 71 118 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><italic>MAT</italic><bold>a</bold><italic>ade2-1 his3-11,15 ura3-52 leu2-3,112 trp1-1</italic></td>
###xml 118 127 118 127 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 43 </td>
###xml 64 127 64 127 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> RS453 </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>MAT</italic><bold>a</bold><italic>ade2-1 his3-11,15 ura3-52 leu2-3,112 trp1-1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 43 </td></tr>
###xml 127 135 127 135 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> SS1026 </td>
###xml 142 152 142 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1::TRP1</italic>
###xml 135 152 135 152 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1</italic></td>
###xml 152 161 152 161 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 10 </td>
###xml 127 161 127 161 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1026 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 10 </td></tr>
###xml 161 169 161 169 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> SS1144 </td>
###xml 176 186 176 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1::HIS3</italic>
###xml 169 186 169 186 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>dgk1::HIS3</italic></td>
###xml 186 198 186 198 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 161 198 161 198 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1144 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>dgk1::HIS3</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 198 206 198 206 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> SS1147 </td>
###xml 213 234 213 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1::TRP1 dgk1::HIS3</italic>
###xml 206 234 206 234 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 dgk1::HIS3</italic></td>
###xml 234 246 234 246 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 198 246 198 246 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1147 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 dgk1::HIS3</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 246 254 246 254 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> SS1246 </td>
###xml 261 284 261 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1::TRP1 gat1::KanMX4</italic>
###xml 254 284 254 284 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 gat1::KanMX4</italic></td>
###xml 284 296 284 296 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 246 296 246 296 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1246 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 gat1::KanMX4</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 296 304 296 304 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> SS1247 </td>
###xml 311 334 311 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1::TRP1 gat2::KanMX4</italic>
###xml 304 334 304 334 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 gat2::KanMX4</italic></td>
###xml 334 346 334 346 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 296 346 296 346 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1247 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 gat2::KanMX4</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 346 354 346 354 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> SS1282 </td>
###xml 361 384 361 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1::TRP1 psd1::KanMX4</italic>
###xml 396 405 396 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3-PAH1</italic>
###xml 354 405 354 405 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 psd1::KanMX4</italic> + YCplac33-<italic>URA3-PAH1</italic></td>
###xml 405 417 405 417 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 346 417 346 417 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1282 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 psd1::KanMX4</italic> + YCplac33-<italic>URA3-PAH1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 417 425 417 425 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> SS1301 </td>
###xml 432 455 432 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1::TRP1 cho2::KanMX4</italic>
###xml 467 476 467 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3-PAH1</italic>
###xml 425 476 425 476 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 cho2::KanMX4</italic> + YCplac33-<italic>URA3-PAH1</italic></td>
###xml 476 488 476 488 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 417 488 417 488 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1301 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 cho2::KanMX4</italic> + YCplac33-<italic>URA3-PAH1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 488 496 488 496 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> SS1290 </td>
###xml 503 526 503 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1::TRP1 opi3::KanMX4</italic>
###xml 538 547 538 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3-PAH1</italic>
###xml 496 547 496 547 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 opi3::KanMX4</italic> + YCplac33-<italic>URA3-PAH1</italic></td>
###xml 547 559 547 559 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 488 559 488 559 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1290 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 opi3::KanMX4</italic> + YCplac33-<italic>URA3-PAH1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 559 567 559 567 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> SS1372 </td>
###xml 582 592 582 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PUS1::URA3</italic>
###xml 567 592 567 592 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> RS453 mCherry-<italic>PUS1::URA3</italic></td>
###xml 592 604 592 604 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 559 604 559 604 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1372 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 mCherry-<italic>PUS1::URA3</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 64 604 64 604 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> RS453 </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>MAT</italic><bold>a</bold><italic>ade2-1 his3-11,15 ura3-52 leu2-3,112 trp1-1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 43 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1026 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 10 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1144 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>dgk1::HIS3</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1147 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 dgk1::HIS3</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1246 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 gat1::KanMX4</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1247 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 gat2::KanMX4</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1282 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 psd1::KanMX4</italic> + YCplac33-<italic>URA3-PAH1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1301 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 cho2::KanMX4</italic> + YCplac33-<italic>URA3-PAH1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1290 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 opi3::KanMX4</italic> + YCplac33-<italic>URA3-PAH1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1372 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 mCherry-<italic>PUS1::URA3</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr></tbody>
###xml 39 604 39 604 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="left" valign="bottom"><bold>Strain</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Genotype</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Ref./source</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> RS453 </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>MAT</italic><bold>a</bold><italic>ade2-1 his3-11,15 ura3-52 leu2-3,112 trp1-1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 43 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1026 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 10 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1144 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>dgk1::HIS3</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1147 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 dgk1::HIS3</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1246 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 gat1::KanMX4</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1247 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 gat2::KanMX4</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1282 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 psd1::KanMX4</italic> + YCplac33-<italic>URA3-PAH1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1301 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 cho2::KanMX4</italic> + YCplac33-<italic>URA3-PAH1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1290 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 opi3::KanMX4</italic> + YCplac33-<italic>URA3-PAH1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1372 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 mCherry-<italic>PUS1::URA3</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr></tbody></table>
###xml 0 604 0 604 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tbl1"><label>TABLE 1</label><caption><p textid="17"><bold>Yeast strains used in this study</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="left" valign="bottom"><bold>Strain</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Genotype</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Ref./source</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> RS453 </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>MAT</italic><bold>a</bold><italic>ade2-1 his3-11,15 ura3-52 leu2-3,112 trp1-1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 43 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1026 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 10 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1144 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>dgk1::HIS3</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1147 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 dgk1::HIS3</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1246 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 gat1::KanMX4</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1247 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 gat2::KanMX4</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1282 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 psd1::KanMX4</italic> + YCplac33-<italic>URA3-PAH1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1301 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 cho2::KanMX4</italic> + YCplac33-<italic>URA3-PAH1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1290 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 <italic>pah1::TRP1 opi3::KanMX4</italic> + YCplac33-<italic>URA3-PAH1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> SS1372 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> RS453 mCherry-<italic>PUS1::URA3</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr></tbody></table></table-wrap>
TABLE 1Yeast strains used in this studyStrainGenotypeRef./source RS453 MATaade2-1 his3-11,15 ura3-52 leu2-3,112 trp1-1 Ref. 43  SS1026  RS453 pah1::TRP1 Ref. 10  SS1144  RS453 dgk1::HIS3 This study  SS1147  RS453 pah1::TRP1 dgk1::HIS3 This study  SS1246  RS453 pah1::TRP1 gat1::KanMX4 This study  SS1247  RS453 pah1::TRP1 gat2::KanMX4 This study  SS1282  RS453 pah1::TRP1 psd1::KanMX4 + YCplac33-URA3-PAH1 This study  SS1301  RS453 pah1::TRP1 cho2::KanMX4 + YCplac33-URA3-PAH1 This study  SS1290  RS453 pah1::TRP1 opi3::KanMX4 + YCplac33-URA3-PAH1 This study  SS1372  RS453 mCherry-PUS1::URA3 This study 
###end p 16
###begin p 17
###xml 0 32 0 32 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Yeast strains used in this study</bold>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast strains used in this study
###end p 17
###begin p 18
###xml 0 41 0 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmids and Construction of Fusion Genes</italic>
###xml 88 95 88 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table 2</xref>
###xml 234 238 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAT2</italic>
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 314 318 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 323 327 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 370 374 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 375 377 375 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10</italic>
###xml 392 396 392 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RTN2</italic>
###xml 477 481 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RTN2</italic>
###xml 529 533 529 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3</italic>
###xml 590 594 590 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RTN2</italic>
###xml 609 613 609 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HEH2</italic>
###xml 694 698 694 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HEH2</italic>
###xml 746 750 746 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEU2</italic>
###xml 808 812 808 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOP1</italic>
###xml 835 839 835 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PUS1</italic>
###xml 922 926 922 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PUS1</italic>
###xml 1017 1021 1017 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOP1</italic>
###xml 1040 1044 1040 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 1053 1057 1053 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 1164 1168 1164 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 1205 1209 1205 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOP1</italic>
###xml 1213 1217 1213 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 1246 1250 1246 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 1337 1341 1337 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 1386 1390 1386 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 1391 1393 1391 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10</italic>
Plasmids and Construction of Fusion Genes-The plasmids used in this study are listed in Table 2. The high copy library used for the suppressor screens was from American Type Culture Collection (catalog no. 37323). The construction of GAT2(G253L) and DGK1(D177A) was done by PCR-mediated mutagenesis. The wild-type DGK1 and DGK1(D177A) genes were overexpressed using the GAL1/10 promoter. The RTN2-GFP fusion was constructed by inserting the GFP fragment into the C terminus of RTN2. The fusion gene was cloned into a centromeric URA3 vector (YCplac33), and its expression was driven by the RTN2 promoter. The HEH2-GFP fusion was constructed by inserting the GFP fragment into the C terminus of HEH2. The fusion gene was cloned into a centromeric LEU2 vector (YCplac111), and its expression was driven by the NOP1 promoter. The mCherry-PUS1 fusion was constructed by introducing the mCherry fragment into the N terminus of PUS1. The fusion gene was cloned into a YIplac211 vector, and its expression was driven by the NOP1 promoter. The PtA-DGK1 and GFP-DGK1 fusions were constructed by inserting the protein A or GFP fragment, respectively, into the N terminus of DGK1; their expression was driven by the NOP1 or DGK1 promoter, respectively. The DGK1-PtA fusion was constructed by inserting the protein A fragment into the C terminus of DGK1, and its expression was driven by inducible GAL1/10 promoter.
###end p 18
###begin p 19
###xml 0 7 0 7 <label xmlns:xlink="http://www.w3.org/1999/xlink">TABLE 2</label>
###xml 7 34 7 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Plasmids used in this study</bold>
###xml 7 34 7 34 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="20"><bold>Plasmids used in this study</bold></p>
###xml 7 34 7 34 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="20"><bold>Plasmids used in this study</bold></p></caption>
###xml 34 41 34 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Plasmid</bold>
###xml 34 41 34 41 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"><bold>Plasmid</bold></th>
###xml 41 52 41 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Description</bold>
###xml 41 52 41 52 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><bold>Description</bold></th>
###xml 52 63 52 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ref./source</bold>
###xml 52 63 52 63 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><bold>Ref./source</bold></th>
###xml 34 63 34 63 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th colspan="1" rowspan="1" align="left" valign="bottom"><bold>Plasmid</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Description</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Ref./source</bold></th></tr>
###xml 34 63 34 63 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th colspan="1" rowspan="1" align="left" valign="bottom"><bold>Plasmid</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Description</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Ref./source</bold></th></tr></thead>
###xml 74 79 74 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 63 84 63 84 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>SEC63</italic>-GFP </td>
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 131 139 131 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CEN/LEU2</italic>
###xml 84 147 84 147 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><italic>SEC63</italic>-GFP under control of <italic>SEC63</italic> promoter into <italic>CEN/LEU2</italic> vector </td>
###xml 147 156 147 156 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 10 </td>
###xml 63 156 63 156 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>SEC63</italic>-GFP </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>SEC63</italic>-GFP under control of <italic>SEC63</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 10 </td></tr>
###xml 166 171 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 156 176 156 176 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>SEC63</italic>-GFP </td>
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 223 231 223 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CEN/URA3</italic>
###xml 176 239 176 239 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><italic>SEC63</italic>-GFP under control of <italic>SEC63</italic> promoter into <italic>CEN/URA3</italic> vector </td>
###xml 239 251 239 251 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 156 251 156 251 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>SEC63</italic>-GFP </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>SEC63</italic>-GFP under control of <italic>SEC63</italic> promoter into <italic>CEN/URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 262 266 262 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 251 270 251 270 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> YEplac195-<italic>PAH1</italic>-7P </td>
###xml 270 274 270 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 295 302 295 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1/10</italic>
###xml 321 325 320 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3</italic>
###xml 270 333 270 332 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><italic>PAH1</italic>-7P under control of <italic>GAL1/10</italic> promoter into 2&#956;/<italic>URA3</italic> vector </td>
###xml 333 345 332 344 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 251 345 251 344 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> YEplac195-<italic>PAH1</italic>-7P </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>PAH1</italic>-7P under control of <italic>GAL1/10</italic> promoter into 2&#956;/<italic>URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 355 367 354 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1/10-NEM1</italic>
###xml 345 367 344 366 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>GAL1/10-NEM1</italic></td>
###xml 367 371 366 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NEM1</italic>
###xml 389 396 388 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1/10</italic>
###xml 411 419 410 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CEN/URA3</italic>
###xml 367 427 366 426 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><italic>NEM1</italic> under control of <italic>GAL1/10</italic> promoter into <italic>CEN/URA3</italic> vector </td>
###xml 427 439 426 438 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 345 439 344 438 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>GAL1/10-NEM1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>NEM1</italic> under control of <italic>GAL1/10</italic> promoter into <italic>CEN/URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 447 459 446 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1/10-SPO7</italic>
###xml 439 459 438 458 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> pRS313-<italic>GAL1/10-SPO7</italic></td>
###xml 459 463 458 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPO7</italic>
###xml 481 488 480 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1/10</italic>
###xml 503 506 502 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CEN</italic>
###xml 459 519 458 518 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><italic>SPO7</italic> under control of <italic>GAL1/10</italic> promoter into <italic>CEN</italic>/HIS3 vector </td>
###xml 519 531 518 530 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 439 531 438 530 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> pRS313-<italic>GAL1/10-SPO7</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>SPO7</italic> under control of <italic>GAL1/10</italic> promoter into <italic>CEN</italic>/HIS3 vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 542 554 541 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1/10-DGK1</italic>
###xml 531 554 530 553 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAL1/10-DGK1</italic></td>
###xml 554 558 553 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 576 583 575 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1/10</italic>
###xml 598 606 597 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CEN/LEU2</italic>
###xml 554 614 553 613 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><italic>DGK1</italic> under control of <italic>GAL1/10</italic> promoter into <italic>CEN/LEU2</italic> vector </td>
###xml 614 626 613 625 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 531 626 530 625 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAL1/10-DGK1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>DGK1</italic> under control of <italic>GAL1/10</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 637 649 636 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1/10-DGK1</italic>
###xml 626 649 625 648 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> YEplac181-<italic>GAL1/10-DGK1</italic></td>
###xml 649 653 648 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 671 678 670 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1/10</italic>
###xml 697 701 695 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEU2</italic>
###xml 649 709 648 707 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><italic>DGK1</italic> under control of <italic>GAL1/10</italic> promoter into 2&#956;/<italic>LEU2</italic> vector </td>
###xml 709 721 707 719 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 626 721 625 719 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> YEplac181-<italic>GAL1/10-DGK1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>DGK1</italic> under control of <italic>GAL1/10</italic> promoter into 2&#956;/<italic>LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 733 737 731 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PUS1</italic>
###xml 721 737 719 735 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> pRS313-RFP-<italic>PUS1</italic></td>
###xml 737 741 735 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PUS1</italic>
###xml 759 763 757 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOP1</italic>
###xml 778 781 776 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CEN</italic>
###xml 737 794 735 792 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><italic>PUS1</italic> under control of <italic>NOP1</italic> promoter into <italic>CEN</italic>/HIS3 vector </td>
###xml 794 806 792 804 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 721 806 719 804 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> pRS313-RFP-<italic>PUS1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>PUS1</italic> under control of <italic>NOP1</italic> promoter into <italic>CEN</italic>/HIS3 vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 817 829 815 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1/10-DGK1</italic>
###xml 806 837 804 835 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAL1/10-DGK1</italic>(D177A) </td>
###xml 837 841 835 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 866 873 864 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1/10</italic>
###xml 888 896 886 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CEN/LEU2</italic>
###xml 837 904 835 902 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><italic>DGK1</italic>(D177A) under control of <italic>GAL1/10</italic> promoter into <italic>CEN/LEU2</italic> vector </td>
###xml 904 916 902 914 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 806 916 804 914 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAL1/10-DGK1</italic>(D177A) </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>DGK1</italic>(D177A) under control of <italic>GAL1/10</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 935 939 933 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PUS1</italic>
###xml 916 939 914 937 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> YIplac211-mCherry-<italic>PUS1</italic></td>
###xml 939 943 937 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PUS1</italic>
###xml 961 965 959 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOP1</italic>
###xml 992 996 990 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3</italic>
###xml 939 1004 937 1002 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><italic>PUS1</italic> under control of <italic>NOP1</italic> promoter into integrative/<italic>URA3</italic> vector </td>
###xml 1004 1016 1002 1014 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 916 1016 914 1014 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> YIplac211-mCherry-<italic>PUS1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>PUS1</italic> under control of <italic>NOP1</italic> promoter into integrative/<italic>URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 1026 1030 1024 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RTN2</italic>
###xml 1016 1035 1014 1033 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>RTN2</italic>-GFP </td>
###xml 1035 1039 1033 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RTN2</italic>
###xml 1061 1065 1059 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RTN2</italic>
###xml 1080 1088 1078 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CEN/URA3</italic>
###xml 1035 1096 1033 1094 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><italic>RTN2</italic>-GFP under control of <italic>RTN2</italic> promoter into <italic>CEN/URA3</italic> vector </td>
###xml 1096 1108 1094 1106 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 1016 1108 1014 1106 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>RTN2</italic>-GFP </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>RTN2</italic>-GFP under control of <italic>RTN2</italic> promoter into <italic>CEN/URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 1119 1123 1117 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HEH2</italic>
###xml 1108 1128 1106 1126 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>HEH2</italic>-GFP </td>
###xml 1128 1132 1126 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HEH2</italic>
###xml 1154 1158 1152 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOP1</italic>
###xml 1173 1181 1171 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CEN/LEU2</italic>
###xml 1128 1189 1126 1187 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><italic>HEH2</italic>-GFP under control of <italic>NOP1</italic> promoter into <italic>CEN/LEU2</italic> vector </td>
###xml 1189 1201 1187 1199 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 1108 1201 1106 1199 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>HEH2</italic>-GFP </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>HEH2</italic>-GFP under control of <italic>NOP1</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 1211 1215 1209 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 1201 1215 1199 1213 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>PAH1</italic></td>
###xml 1215 1219 1213 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 1237 1241 1235 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 1256 1264 1254 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CEN/URA3</italic>
###xml 1215 1272 1213 1270 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><italic>PAH1</italic> under control of <italic>PAH1</italic> promoter into <italic>CEN/URA3</italic> vector </td>
###xml 1272 1281 1270 1279 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 10 </td>
###xml 1201 1281 1199 1279 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>PAH1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>PAH1</italic> under control of <italic>PAH1</italic> promoter into <italic>CEN/URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 10 </td></tr>
###xml 1281 1293 1279 1291 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> pRS426-G20 </td>
###xml 1298 1303 1296 1301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPO20</italic>
###xml 1329 1333 1327 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TEF2</italic>
###xml 1352 1356 1349 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3</italic>
###xml 1293 1364 1291 1361 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> GFP-<italic>SPO20</italic>-(51-91) under control of <italic>TEF2</italic> promoter into 2&#956;/<italic>URA3</italic> vector </td>
###xml 1364 1373 1361 1370 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 26 </td>
###xml 1281 1373 1279 1370 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> pRS426-G20 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> GFP-<italic>SPO20</italic>-(51-91) under control of <italic>TEF2</italic> promoter into 2&#956;/<italic>URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 26 </td></tr>
###xml 1373 1392 1370 1389 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> pRS424-GAL1pr-DGK </td>
###xml 1424 1428 1421 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 1447 1451 1443 1447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRP1</italic>
###xml 1392 1459 1389 1455 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> Bacterial DGK under control of <italic>GAL1</italic> promoter into 2&#956;/<italic>TRP1</italic> vector </td>
###xml 1459 1468 1455 1464 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 26 </td>
###xml 1373 1468 1370 1464 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> pRS424-GAL1pr-DGK </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Bacterial DGK under control of <italic>GAL1</italic> promoter into 2&#956;/<italic>TRP1</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 26 </td></tr>
###xml 1479 1483 1475 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAT2</italic>
###xml 1468 1483 1464 1479 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAT2</italic></td>
###xml 1483 1487 1479 1483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAT2</italic>
###xml 1505 1509 1501 1505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAT2</italic>
###xml 1524 1532 1520 1528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CEN/LEU2</italic>
###xml 1483 1540 1479 1536 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><italic>GAT2</italic> under control of <italic>GAT2</italic> promoter into <italic>CEN/LEU2</italic> vector </td>
###xml 1540 1552 1536 1548 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 1468 1552 1464 1548 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAT2</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>GAT2</italic> under control of <italic>GAT2</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 1563 1567 1559 1563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAT2</italic>
###xml 1552 1575 1548 1571 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAT2</italic>(G253L) </td>
###xml 1575 1579 1571 1575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAT2</italic>
###xml 1604 1608 1600 1604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAT2</italic>
###xml 1623 1631 1619 1627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CEN/LEU2</italic>
###xml 1575 1639 1571 1635 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"><italic>GAT2</italic>(G253L) under control of <italic>GAT2</italic> promoter into <italic>CEN/LEU2</italic> vector </td>
###xml 1639 1651 1635 1647 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="bottom"> This study </td>
###xml 1552 1651 1548 1647 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAT2</italic>(G253L) </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>GAT2</italic>(G253L) under control of <italic>GAT2</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr>
###xml 63 1651 63 1647 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>SEC63</italic>-GFP </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>SEC63</italic>-GFP under control of <italic>SEC63</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 10 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>SEC63</italic>-GFP </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>SEC63</italic>-GFP under control of <italic>SEC63</italic> promoter into <italic>CEN/URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YEplac195-<italic>PAH1</italic>-7P </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>PAH1</italic>-7P under control of <italic>GAL1/10</italic> promoter into 2&#956;/<italic>URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>GAL1/10-NEM1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>NEM1</italic> under control of <italic>GAL1/10</italic> promoter into <italic>CEN/URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> pRS313-<italic>GAL1/10-SPO7</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>SPO7</italic> under control of <italic>GAL1/10</italic> promoter into <italic>CEN</italic>/HIS3 vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAL1/10-DGK1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>DGK1</italic> under control of <italic>GAL1/10</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YEplac181-<italic>GAL1/10-DGK1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>DGK1</italic> under control of <italic>GAL1/10</italic> promoter into 2&#956;/<italic>LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> pRS313-RFP-<italic>PUS1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>PUS1</italic> under control of <italic>NOP1</italic> promoter into <italic>CEN</italic>/HIS3 vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAL1/10-DGK1</italic>(D177A) </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>DGK1</italic>(D177A) under control of <italic>GAL1/10</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YIplac211-mCherry-<italic>PUS1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>PUS1</italic> under control of <italic>NOP1</italic> promoter into integrative/<italic>URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>RTN2</italic>-GFP </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>RTN2</italic>-GFP under control of <italic>RTN2</italic> promoter into <italic>CEN/URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>HEH2</italic>-GFP </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>HEH2</italic>-GFP under control of <italic>NOP1</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>PAH1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>PAH1</italic> under control of <italic>PAH1</italic> promoter into <italic>CEN/URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 10 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> pRS426-G20 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> GFP-<italic>SPO20</italic>-(51-91) under control of <italic>TEF2</italic> promoter into 2&#956;/<italic>URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 26 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> pRS424-GAL1pr-DGK </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Bacterial DGK under control of <italic>GAL1</italic> promoter into 2&#956;/<italic>TRP1</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 26 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAT2</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>GAT2</italic> under control of <italic>GAT2</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAT2</italic>(G253L) </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>GAT2</italic>(G253L) under control of <italic>GAT2</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr></tbody>
###xml 34 1651 34 1647 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="left" valign="bottom"><bold>Plasmid</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Description</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Ref./source</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>SEC63</italic>-GFP </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>SEC63</italic>-GFP under control of <italic>SEC63</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 10 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>SEC63</italic>-GFP </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>SEC63</italic>-GFP under control of <italic>SEC63</italic> promoter into <italic>CEN/URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YEplac195-<italic>PAH1</italic>-7P </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>PAH1</italic>-7P under control of <italic>GAL1/10</italic> promoter into 2&#956;/<italic>URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>GAL1/10-NEM1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>NEM1</italic> under control of <italic>GAL1/10</italic> promoter into <italic>CEN/URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> pRS313-<italic>GAL1/10-SPO7</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>SPO7</italic> under control of <italic>GAL1/10</italic> promoter into <italic>CEN</italic>/HIS3 vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAL1/10-DGK1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>DGK1</italic> under control of <italic>GAL1/10</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YEplac181-<italic>GAL1/10-DGK1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>DGK1</italic> under control of <italic>GAL1/10</italic> promoter into 2&#956;/<italic>LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> pRS313-RFP-<italic>PUS1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>PUS1</italic> under control of <italic>NOP1</italic> promoter into <italic>CEN</italic>/HIS3 vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAL1/10-DGK1</italic>(D177A) </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>DGK1</italic>(D177A) under control of <italic>GAL1/10</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YIplac211-mCherry-<italic>PUS1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>PUS1</italic> under control of <italic>NOP1</italic> promoter into integrative/<italic>URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>RTN2</italic>-GFP </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>RTN2</italic>-GFP under control of <italic>RTN2</italic> promoter into <italic>CEN/URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>HEH2</italic>-GFP </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>HEH2</italic>-GFP under control of <italic>NOP1</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>PAH1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>PAH1</italic> under control of <italic>PAH1</italic> promoter into <italic>CEN/URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 10 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> pRS426-G20 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> GFP-<italic>SPO20</italic>-(51-91) under control of <italic>TEF2</italic> promoter into 2&#956;/<italic>URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 26 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> pRS424-GAL1pr-DGK </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Bacterial DGK under control of <italic>GAL1</italic> promoter into 2&#956;/<italic>TRP1</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 26 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAT2</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>GAT2</italic> under control of <italic>GAT2</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAT2</italic>(G253L) </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>GAT2</italic>(G253L) under control of <italic>GAT2</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr></tbody></table>
###xml 0 1651 0 1647 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tbl2"><label>TABLE 2</label><caption><p textid="20"><bold>Plasmids used in this study</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="left" valign="bottom"><bold>Plasmid</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Description</bold></th><th colspan="1" rowspan="1" align="center" valign="bottom"><bold>Ref./source</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>SEC63</italic>-GFP </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>SEC63</italic>-GFP under control of <italic>SEC63</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 10 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>SEC63</italic>-GFP </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>SEC63</italic>-GFP under control of <italic>SEC63</italic> promoter into <italic>CEN/URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YEplac195-<italic>PAH1</italic>-7P </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>PAH1</italic>-7P under control of <italic>GAL1/10</italic> promoter into 2&#956;/<italic>URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>GAL1/10-NEM1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>NEM1</italic> under control of <italic>GAL1/10</italic> promoter into <italic>CEN/URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> pRS313-<italic>GAL1/10-SPO7</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>SPO7</italic> under control of <italic>GAL1/10</italic> promoter into <italic>CEN</italic>/HIS3 vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAL1/10-DGK1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>DGK1</italic> under control of <italic>GAL1/10</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YEplac181-<italic>GAL1/10-DGK1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>DGK1</italic> under control of <italic>GAL1/10</italic> promoter into 2&#956;/<italic>LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> pRS313-RFP-<italic>PUS1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>PUS1</italic> under control of <italic>NOP1</italic> promoter into <italic>CEN</italic>/HIS3 vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAL1/10-DGK1</italic>(D177A) </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>DGK1</italic>(D177A) under control of <italic>GAL1/10</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YIplac211-mCherry-<italic>PUS1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>PUS1</italic> under control of <italic>NOP1</italic> promoter into integrative/<italic>URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>RTN2</italic>-GFP </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>RTN2</italic>-GFP under control of <italic>RTN2</italic> promoter into <italic>CEN/URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>HEH2</italic>-GFP </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>HEH2</italic>-GFP under control of <italic>NOP1</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac33-<italic>PAH1</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>PAH1</italic> under control of <italic>PAH1</italic> promoter into <italic>CEN/URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 10 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> pRS426-G20 </td><td colspan="1" rowspan="1" align="center" valign="bottom"> GFP-<italic>SPO20</italic>-(51-91) under control of <italic>TEF2</italic> promoter into 2&#956;/<italic>URA3</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 26 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> pRS424-GAL1pr-DGK </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Bacterial DGK under control of <italic>GAL1</italic> promoter into 2&#956;/<italic>TRP1</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> Ref. 26 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAT2</italic></td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>GAT2</italic> under control of <italic>GAT2</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="bottom"> YCplac111-<italic>GAT2</italic>(G253L) </td><td colspan="1" rowspan="1" align="center" valign="bottom"><italic>GAT2</italic>(G253L) under control of <italic>GAT2</italic> promoter into <italic>CEN/LEU2</italic> vector </td><td colspan="1" rowspan="1" align="center" valign="bottom"> This study </td></tr></tbody></table></table-wrap>
TABLE 2Plasmids used in this studyPlasmidDescriptionRef./source YCplac111-SEC63-GFP SEC63-GFP under control of SEC63 promoter into CEN/LEU2 vector  Ref. 10  YCplac33-SEC63-GFP SEC63-GFP under control of SEC63 promoter into CEN/URA3 vector  This study  YEplac195-PAH1-7P PAH1-7P under control of GAL1/10 promoter into 2mu/URA3 vector  This study  YCplac33-GAL1/10-NEM1NEM1 under control of GAL1/10 promoter into CEN/URA3 vector  This study  pRS313-GAL1/10-SPO7SPO7 under control of GAL1/10 promoter into CEN/HIS3 vector  This study  YCplac111-GAL1/10-DGK1DGK1 under control of GAL1/10 promoter into CEN/LEU2 vector  This study  YEplac181-GAL1/10-DGK1DGK1 under control of GAL1/10 promoter into 2mu/LEU2 vector  This study  pRS313-RFP-PUS1PUS1 under control of NOP1 promoter into CEN/HIS3 vector  This study  YCplac111-GAL1/10-DGK1(D177A) DGK1(D177A) under control of GAL1/10 promoter into CEN/LEU2 vector  This study  YIplac211-mCherry-PUS1PUS1 under control of NOP1 promoter into integrative/URA3 vector  This study  YCplac33-RTN2-GFP RTN2-GFP under control of RTN2 promoter into CEN/URA3 vector  This study  YCplac111-HEH2-GFP HEH2-GFP under control of NOP1 promoter into CEN/LEU2 vector  This study  YCplac33-PAH1PAH1 under control of PAH1 promoter into CEN/URA3 vector  Ref. 10  pRS426-G20  GFP-SPO20-(51-91) under control of TEF2 promoter into 2mu/URA3 vector  Ref. 26  pRS424-GAL1pr-DGK  Bacterial DGK under control of GAL1 promoter into 2mu/TRP1 vector  Ref. 26  YCplac111-GAT2GAT2 under control of GAT2 promoter into CEN/LEU2 vector  This study  YCplac111-GAT2(G253L) GAT2(G253L) under control of GAT2 promoter into CEN/LEU2 vector  This study 
###end p 19
###begin p 20
###xml 0 27 0 27 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Plasmids used in this study</bold>
Plasmids used in this study
###end p 20
###begin p 21
###xml 0 35 0 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">High Copy Number Suppressor Screens</italic>
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 145 147 145 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10</italic>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 356 360 356 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 717 721 717 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 797 802 797 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1-</italic>
###xml 225 230 <span type="species:ncbi:4932">yeast</span>
High Copy Number Suppressor Screens-For the PAH1-7P suppressor screen, the wild-type RS453 strain overexpressing PAH1-7P from the inducible GAL1/10 promoter in a high copy plasmid (YEplac195) was transformed with a high copy yeast genomic library (15). About 5000 transformants were screened for their ability to suppress the toxicity of the overexpressed PAH1-7P mutant on galactose plates lacking inositol (11). Library plasmids were recovered from two suppressor colonies and then retransformed into the original screening strain to verify the suppression. Sequencing of the two library plasmids followed by subcloning of various open reading frames present in the genomic fragment showed that, in both cases, the DGK1 gene was responsible for the suppression of the inositol auxotrophy of the PAH1-7P mutant.
###end p 21
###begin p 22
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NEM1</italic>
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPO7</italic>
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NEM1</italic>
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPO7</italic>
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 107 109 107 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10</italic>
###xml 335 339 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NEM1</italic>
###xml 340 344 340 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPO7</italic>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 486 490 486 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 534 538 534 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 582 586 582 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NEM1</italic>
###xml 587 591 587 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPO7</italic>
For the NEM1-SPO7 suppressor screen, the wild-type RS453 strain overexpressing NEM1 and SPO7 from the GAL1/10 promoter in the YCplac33 and pRS313 plasmids, respectively, was transformed with the same high copy genomic library as described above. About 6000 transformants were screened for their ability to suppress the toxicity of the NEM1-SPO7 overexpression (10). Four suppressors were isolated that were found, when analyzed as described above, to contain overlapping inserts of the DGK1 gene. Further subcloning demonstrated that DGK1 was responsible for the suppression of the NEM1-SPO7 toxicity.
###end p 22
###begin p 23
###xml 0 36 0 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RNA Extractions and Quantitative PCR</italic>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
RNA Extractions and Quantitative PCR-Total RNA was isolated as described previously (11). Quantitative real-time PCR was performed on total RNA using an ABI 7900HT system and a SYBR Green Mastermix (Applied Biosystems) as described previously (11).
###end p 23
###begin p 24
###xml 0 34 0 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Affinity Purification of PtA-Dgk1p</italic>
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 78 82 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 103 104 99 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 104 107 100 103 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 180 182 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 223 224 219 220 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 234 235 230 231 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 262 263 258 259 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 268 269 264 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 952 954 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 859 877 <span type="species:ncbi:12227">tobacco etch virus</span>
Affinity Purification of PtA-Dgk1p-The dgk1Delta strain carrying a pRS315-PtA-DGK1 fusion was grown to A600 = 1, washed once with water, and spheroplasted as described previously (16). Spheroplasts were first lysed in 150 mm KCl, 20 mm Tris-HCl (pH 8.0), and 5 mm MgCl2 supplemented with a mixture of protease inhibitors (Complete EDTA-free, Roche Applied Science) and 4-(2-aminoethyl)benzenesulfonyl fluoride. The extract was centrifuged for 15 min at 15,000 rpm (Sorvall SS34 rotor), and the pellet was resuspended in the same lysis buffer containing 1% Triton X-100. The extract was centrifuged for 30 min as described above, and the supernatant was first pre-cleared by incubation with Sepharose Fast-Flow beads (GE Healthcare) and then loaded onto a column packed with IgG-Sepharose beads (GE Healthcare). Affinity purifications of PtA-Dgk1p followed by tobacco etch virus protease-dependent elution of untagged Dgk1p were performed as described (16).
###end p 24
###begin p 25
###xml 0 26 0 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Preparation of Labeled CTP</italic>
###xml 34 36 30 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 92 94 84 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 160 162 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
Preparation of Labeled CTP-[gamma-32P]CTP was synthesized enzymatically from CDP and [gamma-32P]ATP with nucleoside-diphosphate kinase as described previously (17).
###end p 25
###begin p 26
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DAG Kinase Assay</italic>
###xml 102 103 102 103 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 118 119 118 119 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 127 129 123 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 176 177 172 173 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 200 201 196 197 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 219 220 215 216 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 225 226 221 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 232 233 228 229 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 301 302 294 295 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 380 381 367 368 <sc xmlns:xlink="http://www.w3.org/1999/xlink">n</sc>
###xml 556 558 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
DAG Kinase Assay-DAG kinase activity was measured for 20 min by following the phosphorylation of 0.1 mm DAG with 0.1 mm [gamma-32P]CTP (50,000 cpm/nmol) in the presence of 50 mm Tris-HCl (pH 7.5), 1 mm Triton X-100, 5 mm CaCl2, 10 mm beta-mercaptoethanol, and enzyme protein in a total volume of 0.1 mm at 30 degreesC. The reaction was terminated by the addition of 0.5 ml of 0.1 n HCl in methanol. The radioactive chloroform-soluble product PA was separated from the radioactive water-soluble substrate CTP by a chloroform/methanol/water phase partition (18). The radioactive chloroform phase was subjected to liquid scintillation counting. Alternatively, the product was subjected to thin layer chromatography using a solvent system of chloroform/methanol/water (65:25:4, v/v) and visualized by phosphorimaging. The DAG kinase assay was conducted in triplicate, and the average S.D. of the assay was +/-5%. The enzyme reaction was linear with time and protein concentration.
###end p 26
###begin p 27
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Labeling and Analysis of Lipids</italic>
###xml 95 97 95 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 98 99 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 107 109 107 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
Labeling and Analysis of Lipids-Steady-state labeling of phospholipids and neutral lipids with 32Pi and [2-14C]acetate, respectively, was performed as described previously (9). Phospholipids were separated by two-dimensional thin layer chromatography on silica gel plates using chloroform/methanol/ammonium hydroxide/water (45:25:2:3, v/v) and chloroform/methanol/glacial acetic acid/water (32:4:5:1, v/v) as the solvent systems for the first and second dimensions, respectively. Neutral lipids were separated by one-dimensional thin layer chromatography on silica gel plates using a solvent system of hexane/diethyl ether/glacial acetic acid (40:10:1, v/v). The identity of the labeled lipids on thin layer chromatography plates was confirmed by comparison with standards after exposure to iodine vapor. Radiolabeled lipids were visualized by phosphorimaging and subjected to ImageQuant analysis.
###end p 27
###begin p 28
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Microscopy</italic>
###xml 334 335 328 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 333 335 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">2<italic>D</italic></xref>
###xml 341 342 335 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 340 342 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">6<italic>C</italic></xref>
Microscopy-To visualize GFP, red fluorescent protein, and mCherry fusions, cells were grown in the appropriate selective medium at 30 degreesC to early logarithmic phase and examined with a x63 Plan Apochromat objective on a Zeiss Axiovert 200 M inverted microscope with an LSM 510 confocal laser scanning attachment. Cells in Figs. 2D and 6C were viewed using a Zeiss Axiophot fluorescence microscope equipped with a CCD camera, and images were recorded using IP Labs software.
###end p 28
###begin p 29
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Antibodies</italic>
Antibodies-The antibody used to detect protein A fusions was from DAKO (catalog no. Z0113).
###end p 29
###begin title 30
RESULTS
###end title 30
###begin p 31
###xml 0 93 0 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Systematic Analysis of the Function of Phospholipid Biosynthetic Enzymes in Nuclear Structure</italic>
###xml 117 119 117 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 276 277 276 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 563 568 563 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 796 797 796 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 790 797 790 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 944 945 944 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 938 945 938 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 1125 1126 1125 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1119 1126 1119 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 1217 1221 1217 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
Systematic Analysis of the Function of Phospholipid Biosynthetic Enzymes in Nuclear Structure-Pah1p is a conserved Mg2+-dependent PA phosphatase required for phospholipid and triacylglycerol synthesis (9). Inactivation of Pah1p leads to changes in PA and phospholipid levels (9) and results in a massive expansion of the nuclear/ER membrane (10). To address the possible role of distinct lipid species in nuclear structure, we first asked whether inhibition of other phospholipid biosynthetic steps could have a similar effect on the nuclear/ER membrane. Using a SEC63-GFP fusion as a reporter, we analyzed nuclear/ER membrane structure in a series of mutants lacking the enzymes catalyzing key steps in PA, phosphatidylinositol, phosphatidylserine, PE, and PC biosynthesis (highlighted in Fig. 1A). Partial defects in peripheral ER structure were observed in cells lacking Cho2p and Opi3p, involved in the final steps of PC methylation (Fig. 1C). Depletion of Cds1p, the essential cytidylyltransferase that utilizes PA to synthesize phospholipids via the CDP-DAG pathway, also partially affects cortical ER structure (Fig. 1C). However, nuclear membrane proliferation and nuclear expansion, similar to those seen in pah1Delta cells, were not observed in any of the mutants tested. Therefore, among the different phospholipid biosynthetic steps, the Pah1p-mediated dephosphorylation of PA to DAG plays a unique role in nuclear structure.
###end p 31
###begin p 32
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 9 101 9 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Systematic analysis of the role of phospholipid metabolism in nuclear/ER membrane structure.</bold>
###xml 101 102 101 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 346 350 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Blue</italic>
###xml 355 365 355 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red arrows</italic>
###xml 405 408 405 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cho</italic>
###xml 434 437 434 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G3P</italic>
###xml 461 466 461 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DHAP,</italic>
###xml 495 498 495 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPA</italic>
###xml 523 525 523 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PI</italic>
###xml 549 551 549 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PS</italic>
###xml 573 574 573 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 695 700 695 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 879 883 879 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDS1</italic>
###xml 959 964 958 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 1027 1031 1026 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pis1</italic>
###xml 1184 1188 1171 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDS1</italic>
###xml 1193 1197 1180 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">psd1</italic>
###xml 1252 1256 1235 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pis1</italic>
###xml 1258 1260 1241 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref41">41</xref>
###xml 1266 1270 1249 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1277 1279 1256 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 1290 1291 1269 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1333 1337 1312 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDS1</italic>
###xml 1365 1369 1344 1348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">opi3</italic>
###xml 1390 1395 1365 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 1410 1419 1385 1394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scale bar</italic>
###xml 9 1428 9 1402 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="33"><bold>Systematic analysis of the role of phospholipid metabolism in nuclear/ER membrane structure.</bold><italic>A</italic>, pathways of phospholipid biosynthesis and PA metabolism in budding yeast. Reactions involved in the production of cellular pools of phospholipids are shown. For simplicity, the Kennedy pathway reactions leading to PE synthesis are not shown. <italic>Blue</italic> and <italic>red arrows</italic> highlight the CDP-DAG and CDP-choline (<italic>Cho</italic>) pathways, respectively. <italic>G3P</italic>, glycerol 3-phosphate; <italic>DHAP,</italic> dihydroxyacetone phosphate. <italic>LPA</italic>, lysophosphatidic acid; <italic>PI</italic>, phosphatidylinositol; <italic>PS</italic>, phosphatidylserine. <italic>B</italic>, list of mutants tested for nuclear/ER morphology defects. Cells were transformed with a centromeric plasmid expressing <italic>SEC63</italic>-GFP and visualized by microscopy. At least two transformants per mutant were analyzed. +, no defects in nuclear or ER structure; -, severe defects; +/-, partial defects. The tet-<italic>CDS1</italic> repressible strain was grown in the presence of 10 &#956;g/ml doxycycline, and <italic>SEC63</italic>-GFP fluorescence was visualized after 0, 6, 12, and 24 h. The <italic>pis1</italic> temperature-sensitive strain was grown at 30 &#176;C and then transferred to 37 &#176;C for 3 h. All mutants were derived from BY4742, except the tet-<italic>CDS1</italic> and <italic>psd1</italic>&#916; strains, which were derived from BY4741, and the <italic>pis1</italic> (<xref ref-type="bibr" rid="ref41">41</xref>) and <italic>pah1</italic>&#916; (<xref ref-type="bibr" rid="ref10">10</xref>) strains. <italic>C</italic>, representative images of wild-type, tet-<italic>CDS1</italic> (12 h in doxycycline), and <italic>opi3</italic>&#916; expressing the <italic>SEC63</italic>-GFP reporter. <italic>Scale bar</italic> = 5 &#956;m.</p>
###xml 9 1428 9 1402 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="33"><bold>Systematic analysis of the role of phospholipid metabolism in nuclear/ER membrane structure.</bold><italic>A</italic>, pathways of phospholipid biosynthesis and PA metabolism in budding yeast. Reactions involved in the production of cellular pools of phospholipids are shown. For simplicity, the Kennedy pathway reactions leading to PE synthesis are not shown. <italic>Blue</italic> and <italic>red arrows</italic> highlight the CDP-DAG and CDP-choline (<italic>Cho</italic>) pathways, respectively. <italic>G3P</italic>, glycerol 3-phosphate; <italic>DHAP,</italic> dihydroxyacetone phosphate. <italic>LPA</italic>, lysophosphatidic acid; <italic>PI</italic>, phosphatidylinositol; <italic>PS</italic>, phosphatidylserine. <italic>B</italic>, list of mutants tested for nuclear/ER morphology defects. Cells were transformed with a centromeric plasmid expressing <italic>SEC63</italic>-GFP and visualized by microscopy. At least two transformants per mutant were analyzed. +, no defects in nuclear or ER structure; -, severe defects; +/-, partial defects. The tet-<italic>CDS1</italic> repressible strain was grown in the presence of 10 &#956;g/ml doxycycline, and <italic>SEC63</italic>-GFP fluorescence was visualized after 0, 6, 12, and 24 h. The <italic>pis1</italic> temperature-sensitive strain was grown at 30 &#176;C and then transferred to 37 &#176;C for 3 h. All mutants were derived from BY4742, except the tet-<italic>CDS1</italic> and <italic>psd1</italic>&#916; strains, which were derived from BY4741, and the <italic>pis1</italic> (<xref ref-type="bibr" rid="ref41">41</xref>) and <italic>pah1</italic>&#916; (<xref ref-type="bibr" rid="ref10">10</xref>) strains. <italic>C</italic>, representative images of wild-type, tet-<italic>CDS1</italic> (12 h in doxycycline), and <italic>opi3</italic>&#916; expressing the <italic>SEC63</italic>-GFP reporter. <italic>Scale bar</italic> = 5 &#956;m.</p></caption>
###xml 1428 1428 1402 1402 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0300842590001"/>
###xml 0 1428 0 1402 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="33"><bold>Systematic analysis of the role of phospholipid metabolism in nuclear/ER membrane structure.</bold><italic>A</italic>, pathways of phospholipid biosynthesis and PA metabolism in budding yeast. Reactions involved in the production of cellular pools of phospholipids are shown. For simplicity, the Kennedy pathway reactions leading to PE synthesis are not shown. <italic>Blue</italic> and <italic>red arrows</italic> highlight the CDP-DAG and CDP-choline (<italic>Cho</italic>) pathways, respectively. <italic>G3P</italic>, glycerol 3-phosphate; <italic>DHAP,</italic> dihydroxyacetone phosphate. <italic>LPA</italic>, lysophosphatidic acid; <italic>PI</italic>, phosphatidylinositol; <italic>PS</italic>, phosphatidylserine. <italic>B</italic>, list of mutants tested for nuclear/ER morphology defects. Cells were transformed with a centromeric plasmid expressing <italic>SEC63</italic>-GFP and visualized by microscopy. At least two transformants per mutant were analyzed. +, no defects in nuclear or ER structure; -, severe defects; +/-, partial defects. The tet-<italic>CDS1</italic> repressible strain was grown in the presence of 10 &#956;g/ml doxycycline, and <italic>SEC63</italic>-GFP fluorescence was visualized after 0, 6, 12, and 24 h. The <italic>pis1</italic> temperature-sensitive strain was grown at 30 &#176;C and then transferred to 37 &#176;C for 3 h. All mutants were derived from BY4742, except the tet-<italic>CDS1</italic> and <italic>psd1</italic>&#916; strains, which were derived from BY4741, and the <italic>pis1</italic> (<xref ref-type="bibr" rid="ref41">41</xref>) and <italic>pah1</italic>&#916; (<xref ref-type="bibr" rid="ref10">10</xref>) strains. <italic>C</italic>, representative images of wild-type, tet-<italic>CDS1</italic> (12 h in doxycycline), and <italic>opi3</italic>&#916; expressing the <italic>SEC63</italic>-GFP reporter. <italic>Scale bar</italic> = 5 &#956;m.</p></caption><graphic xlink:href="zbc0300842590001"/></fig>
###xml 171 176 <span type="species:ncbi:4932">yeast</span>
FIGURE 1.Systematic analysis of the role of phospholipid metabolism in nuclear/ER membrane structure.A, pathways of phospholipid biosynthesis and PA metabolism in budding yeast. Reactions involved in the production of cellular pools of phospholipids are shown. For simplicity, the Kennedy pathway reactions leading to PE synthesis are not shown. Blue and red arrows highlight the CDP-DAG and CDP-choline (Cho) pathways, respectively. G3P, glycerol 3-phosphate; DHAP, dihydroxyacetone phosphate. LPA, lysophosphatidic acid; PI, phosphatidylinositol; PS, phosphatidylserine. B, list of mutants tested for nuclear/ER morphology defects. Cells were transformed with a centromeric plasmid expressing SEC63-GFP and visualized by microscopy. At least two transformants per mutant were analyzed. +, no defects in nuclear or ER structure; -, severe defects; +/-, partial defects. The tet-CDS1 repressible strain was grown in the presence of 10 mug/ml doxycycline, and SEC63-GFP fluorescence was visualized after 0, 6, 12, and 24 h. The pis1 temperature-sensitive strain was grown at 30 degreesC and then transferred to 37 degreesC for 3 h. All mutants were derived from BY4742, except the tet-CDS1 and psd1Delta strains, which were derived from BY4741, and the pis1 (41) and pah1Delta (10) strains. C, representative images of wild-type, tet-CDS1 (12 h in doxycycline), and opi3Delta expressing the SEC63-GFP reporter. Scale bar = 5 mum.
###end p 32
###begin p 33
###xml 0 92 0 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Systematic analysis of the role of phospholipid metabolism in nuclear/ER membrane structure.</bold>
###xml 92 93 92 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 337 341 337 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Blue</italic>
###xml 346 356 346 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red arrows</italic>
###xml 396 399 396 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cho</italic>
###xml 425 428 425 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G3P</italic>
###xml 452 457 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DHAP,</italic>
###xml 486 489 486 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LPA</italic>
###xml 514 516 514 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PI</italic>
###xml 540 542 540 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PS</italic>
###xml 564 565 564 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 686 691 686 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 870 874 870 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDS1</italic>
###xml 950 955 949 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 1018 1022 1017 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pis1</italic>
###xml 1175 1179 1162 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDS1</italic>
###xml 1184 1188 1171 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">psd1</italic>
###xml 1243 1247 1226 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pis1</italic>
###xml 1249 1251 1232 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref41">41</xref>
###xml 1257 1261 1240 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1268 1270 1247 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 1281 1282 1260 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1324 1328 1303 1307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDS1</italic>
###xml 1356 1360 1335 1339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">opi3</italic>
###xml 1381 1386 1356 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 1401 1410 1376 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scale bar</italic>
###xml 162 167 <span type="species:ncbi:4932">yeast</span>
Systematic analysis of the role of phospholipid metabolism in nuclear/ER membrane structure.A, pathways of phospholipid biosynthesis and PA metabolism in budding yeast. Reactions involved in the production of cellular pools of phospholipids are shown. For simplicity, the Kennedy pathway reactions leading to PE synthesis are not shown. Blue and red arrows highlight the CDP-DAG and CDP-choline (Cho) pathways, respectively. G3P, glycerol 3-phosphate; DHAP, dihydroxyacetone phosphate. LPA, lysophosphatidic acid; PI, phosphatidylinositol; PS, phosphatidylserine. B, list of mutants tested for nuclear/ER morphology defects. Cells were transformed with a centromeric plasmid expressing SEC63-GFP and visualized by microscopy. At least two transformants per mutant were analyzed. +, no defects in nuclear or ER structure; -, severe defects; +/-, partial defects. The tet-CDS1 repressible strain was grown in the presence of 10 mug/ml doxycycline, and SEC63-GFP fluorescence was visualized after 0, 6, 12, and 24 h. The pis1 temperature-sensitive strain was grown at 30 degreesC and then transferred to 37 degreesC for 3 h. All mutants were derived from BY4742, except the tet-CDS1 and psd1Delta strains, which were derived from BY4741, and the pis1 (41) and pah1Delta (10) strains. C, representative images of wild-type, tet-CDS1 (12 h in doxycycline), and opi3Delta expressing the SEC63-GFP reporter. Scale bar = 5 mum.
###end p 33
###begin p 34
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1.</italic>
###xml 9 61 9 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>DGK1</italic> rescues the lethality of dephosphorylated <italic>PAH1.</italic></bold>
###xml 61 62 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 143 147 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 241 245 241 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 430 440 430 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 456 467 456 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
###xml 485 486 479 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 506 510 500 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 557 561 551 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NEM1</italic>
###xml 562 566 556 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPO7</italic>
###xml 626 630 620 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NEM1</italic>
###xml 635 639 629 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPO7</italic>
###xml 794 804 788 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 820 831 814 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
###xml 848 849 836 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 903 911 891 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray box</italic>
###xml 1024 1026 1012 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref42">42</xref>
###xml 1067 1078 1055 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black lines</italic>
###xml 1142 1143 1130 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1203 1207 1191 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 1240 1244 1228 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 1300 1304 1288 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 1404 1413 1388 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scale bar</italic>
###xml 9 1421 9 1404 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="35"><bold><italic>DGK1</italic> rescues the lethality of dephosphorylated <italic>PAH1.</italic></bold><italic>A</italic>, identification of <italic>DGK1</italic> as a high copy suppressor of the inositol auxotrophy of <italic>PAH1</italic>-7P. The wild-type RS453 strain carrying a high copy vector expressing the non-phosphorylated <italic>PAH1</italic>-7P mutant from a galactose-inducible promoter was transformed with the indicated plasmids. Transformants were grown on synthetic plates lacking inositol and supplemented with glucose (<italic>left panel</italic>) or galactose (<italic>right panel</italic>) at 30 &#176;C. <italic>B</italic>, identification of <italic>DGK1</italic> as a high copy suppressor of the lethality of <italic>NEM1</italic>-<italic>SPO7</italic> overexpression. RS453 cells carrying plasmids coexpressing <italic>NEM1</italic> and <italic>SPO7</italic> from a galactose-inducible promoter were transformed with the indicated plasmids. Transformants were grown on synthetic plates supplemented with glucose (<italic>left panel</italic>) or galactose (<italic>right panel</italic>) at 30&#176;C. <italic>C</italic>, primary structure and hydropathy plot of Dgk1p. The <italic>gray box</italic> indicates the conserved cytidylyltransferase domain within Dgk1p. Below, the hydropathy plot of Dgk1p is given (<xref ref-type="bibr" rid="ref42">42</xref>), using a window of 19 amino acids. The <italic>black lines</italic> indicate the positions of the predicted transmembrane domains. <italic>D</italic>, GFP-Dgk1p localizes to the nuclear membrane and ER. A GFP-<italic>DGK1</italic> fusion under the control of the <italic>DGK1</italic> promoter was expressed from a centromeric plasmid in a <italic>dgk1</italic>&#916; strain. Cells were grown in early logarithmic phase and visualized by fluorescent microscopy. <italic>Scale bar</italic> =5 &#956;m.</p>
###xml 9 1421 9 1404 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="35"><bold><italic>DGK1</italic> rescues the lethality of dephosphorylated <italic>PAH1.</italic></bold><italic>A</italic>, identification of <italic>DGK1</italic> as a high copy suppressor of the inositol auxotrophy of <italic>PAH1</italic>-7P. The wild-type RS453 strain carrying a high copy vector expressing the non-phosphorylated <italic>PAH1</italic>-7P mutant from a galactose-inducible promoter was transformed with the indicated plasmids. Transformants were grown on synthetic plates lacking inositol and supplemented with glucose (<italic>left panel</italic>) or galactose (<italic>right panel</italic>) at 30 &#176;C. <italic>B</italic>, identification of <italic>DGK1</italic> as a high copy suppressor of the lethality of <italic>NEM1</italic>-<italic>SPO7</italic> overexpression. RS453 cells carrying plasmids coexpressing <italic>NEM1</italic> and <italic>SPO7</italic> from a galactose-inducible promoter were transformed with the indicated plasmids. Transformants were grown on synthetic plates supplemented with glucose (<italic>left panel</italic>) or galactose (<italic>right panel</italic>) at 30&#176;C. <italic>C</italic>, primary structure and hydropathy plot of Dgk1p. The <italic>gray box</italic> indicates the conserved cytidylyltransferase domain within Dgk1p. Below, the hydropathy plot of Dgk1p is given (<xref ref-type="bibr" rid="ref42">42</xref>), using a window of 19 amino acids. The <italic>black lines</italic> indicate the positions of the predicted transmembrane domains. <italic>D</italic>, GFP-Dgk1p localizes to the nuclear membrane and ER. A GFP-<italic>DGK1</italic> fusion under the control of the <italic>DGK1</italic> promoter was expressed from a centromeric plasmid in a <italic>dgk1</italic>&#916; strain. Cells were grown in early logarithmic phase and visualized by fluorescent microscopy. <italic>Scale bar</italic> =5 &#956;m.</p></caption>
###xml 1421 1421 1404 1404 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0300842590002"/>
###xml 0 1421 0 1404 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="35"><bold><italic>DGK1</italic> rescues the lethality of dephosphorylated <italic>PAH1.</italic></bold><italic>A</italic>, identification of <italic>DGK1</italic> as a high copy suppressor of the inositol auxotrophy of <italic>PAH1</italic>-7P. The wild-type RS453 strain carrying a high copy vector expressing the non-phosphorylated <italic>PAH1</italic>-7P mutant from a galactose-inducible promoter was transformed with the indicated plasmids. Transformants were grown on synthetic plates lacking inositol and supplemented with glucose (<italic>left panel</italic>) or galactose (<italic>right panel</italic>) at 30 &#176;C. <italic>B</italic>, identification of <italic>DGK1</italic> as a high copy suppressor of the lethality of <italic>NEM1</italic>-<italic>SPO7</italic> overexpression. RS453 cells carrying plasmids coexpressing <italic>NEM1</italic> and <italic>SPO7</italic> from a galactose-inducible promoter were transformed with the indicated plasmids. Transformants were grown on synthetic plates supplemented with glucose (<italic>left panel</italic>) or galactose (<italic>right panel</italic>) at 30&#176;C. <italic>C</italic>, primary structure and hydropathy plot of Dgk1p. The <italic>gray box</italic> indicates the conserved cytidylyltransferase domain within Dgk1p. Below, the hydropathy plot of Dgk1p is given (<xref ref-type="bibr" rid="ref42">42</xref>), using a window of 19 amino acids. The <italic>black lines</italic> indicate the positions of the predicted transmembrane domains. <italic>D</italic>, GFP-Dgk1p localizes to the nuclear membrane and ER. A GFP-<italic>DGK1</italic> fusion under the control of the <italic>DGK1</italic> promoter was expressed from a centromeric plasmid in a <italic>dgk1</italic>&#916; strain. Cells were grown in early logarithmic phase and visualized by fluorescent microscopy. <italic>Scale bar</italic> =5 &#956;m.</p></caption><graphic xlink:href="zbc0300842590002"/></fig>
FIGURE 2.DGK1 rescues the lethality of dephosphorylated PAH1.A, identification of DGK1 as a high copy suppressor of the inositol auxotrophy of PAH1-7P. The wild-type RS453 strain carrying a high copy vector expressing the non-phosphorylated PAH1-7P mutant from a galactose-inducible promoter was transformed with the indicated plasmids. Transformants were grown on synthetic plates lacking inositol and supplemented with glucose (left panel) or galactose (right panel) at 30 degreesC. B, identification of DGK1 as a high copy suppressor of the lethality of NEM1-SPO7 overexpression. RS453 cells carrying plasmids coexpressing NEM1 and SPO7 from a galactose-inducible promoter were transformed with the indicated plasmids. Transformants were grown on synthetic plates supplemented with glucose (left panel) or galactose (right panel) at 30degreesC. C, primary structure and hydropathy plot of Dgk1p. The gray box indicates the conserved cytidylyltransferase domain within Dgk1p. Below, the hydropathy plot of Dgk1p is given (42), using a window of 19 amino acids. The black lines indicate the positions of the predicted transmembrane domains. D, GFP-Dgk1p localizes to the nuclear membrane and ER. A GFP-DGK1 fusion under the control of the DGK1 promoter was expressed from a centromeric plasmid in a dgk1Delta strain. Cells were grown in early logarithmic phase and visualized by fluorescent microscopy. Scale bar =5 mum.
###end p 34
###begin p 35
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1.</italic>
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>DGK1</italic> rescues the lethality of dephosphorylated <italic>PAH1.</italic></bold>
###xml 52 53 52 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 232 236 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 421 431 421 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 447 458 447 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
###xml 476 477 470 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 497 501 491 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 548 552 542 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NEM1</italic>
###xml 553 557 547 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPO7</italic>
###xml 617 621 611 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NEM1</italic>
###xml 626 630 620 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPO7</italic>
###xml 785 795 779 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 811 822 805 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
###xml 839 840 827 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 894 902 882 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray box</italic>
###xml 1015 1017 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref42">42</xref>
###xml 1058 1069 1046 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black lines</italic>
###xml 1133 1134 1121 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1194 1198 1182 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 1231 1235 1219 1223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 1291 1295 1279 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 1395 1404 1379 1388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scale bar</italic>
DGK1 rescues the lethality of dephosphorylated PAH1.A, identification of DGK1 as a high copy suppressor of the inositol auxotrophy of PAH1-7P. The wild-type RS453 strain carrying a high copy vector expressing the non-phosphorylated PAH1-7P mutant from a galactose-inducible promoter was transformed with the indicated plasmids. Transformants were grown on synthetic plates lacking inositol and supplemented with glucose (left panel) or galactose (right panel) at 30 degreesC. B, identification of DGK1 as a high copy suppressor of the lethality of NEM1-SPO7 overexpression. RS453 cells carrying plasmids coexpressing NEM1 and SPO7 from a galactose-inducible promoter were transformed with the indicated plasmids. Transformants were grown on synthetic plates supplemented with glucose (left panel) or galactose (right panel) at 30degreesC. C, primary structure and hydropathy plot of Dgk1p. The gray box indicates the conserved cytidylyltransferase domain within Dgk1p. Below, the hydropathy plot of Dgk1p is given (42), using a window of 19 amino acids. The black lines indicate the positions of the predicted transmembrane domains. D, GFP-Dgk1p localizes to the nuclear membrane and ER. A GFP-DGK1 fusion under the control of the DGK1 promoter was expressed from a centromeric plasmid in a dgk1Delta strain. Cells were grown in early logarithmic phase and visualized by fluorescent microscopy. Scale bar =5 mum.
###end p 35
###begin p 36
###xml 0 67 0 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Genetic Screens for Factors Regulating PA Metabolism Identify Dgk1p</italic>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 598 602 598 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 769 771 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 954 956 954 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 1069 1073 1069 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 1095 1099 1095 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NEM1</italic>
###xml 1100 1104 1100 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPO7</italic>
###xml 1183 1187 1183 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 1209 1213 1209 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HSD1</italic>
###xml 1239 1243 1239 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 1251 1255 1251 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NEM1</italic>
###xml 1256 1260 1256 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPO7</italic>
###xml 1303 1307 1303 1307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 1354 1358 1354 1358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 1359 1361 1359 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10</italic>
###xml 1380 1381 1380 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1386 1387 1386 1387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1372 1387 1372 1387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, <italic>A</italic> and <italic>B</italic></xref>
###xml 1404 1408 1404 1408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 1409 1413 1409 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HSD1</italic>
###xml 1471 1475 1471 1475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sly1</italic>
###xml 1520 1522 1520 1522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 1838 1839 1838 1839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1832 1839 1832 1839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 1984 1985 1984 1985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn5">4</xref>
###xml 2052 2056 2052 2056 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 2115 2116 2115 2116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 2109 2116 2109 2116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>D</italic></xref>
###xml 1910 1915 <span type="species:ncbi:4932">yeast</span>
Genetic Screens for Factors Regulating PA Metabolism Identify Dgk1p-We reasoned that, if PA regulates nuclear/ER membrane biogenesis, then the activity of other proteins that control PA levels might also impact on nuclear/ER structure. We therefore undertook two screens to identify novel genes encoding PA regulators. Both screens are based on our previous finding that the PA phosphatase activity of Pah1p, which controls cellular concentration of PA (9), is inhibited by phosphorylation (11). Expression of constitutively dephosphorylated Pah1p, generated by mutating its phosphorylation sites (PAH1-7P mutant), increases its PA phosphatase activity, represses transcription of phospholipid biosynthetic enzymes, and results in lethality in medium lacking inositol (11). This phenotype is consistent with a decrease in cellular PA levels. Similarly, overexpression of the Nem1p-Spo7p phosphatase complex, which dephosphorylates Pah1p, is also lethal (10). We therefore screened for high copy number suppressors that can rescue the lethality of the overexpression of PAH1-7P (screen I) or the NEM1-SPO7 phosphatase (screen II). Both screens identified independently the same gene, DGK1 (known previously as HSD1). The suppression of the PAH1-7P and NEM1-SPO7 lethality was confirmed by overexpressing DGK1 in the respective strains using the inducible GAL1/10 promoter (Fig. 2, A and B, respectively). DGK1/HSD1 was originally isolated in a screen for suppressors of a sly1 mutant involved in ER-to-Golgi trafficking (19), but its function and mechanism of suppression remained so far unknown. Its gene product, Dgk1p, is a 32.8-kDa protein that consists of a short N-terminal hydrophilic region (residues 1-73) followed by four putative transmembrane domains containing a predicted cytidylyltransferase domain (residues 74-288) (Fig. 2C). BLAST searches identified putative Dgk1p orthologs in several other yeast species, but not any apparent related proteins in higher eukaryotes.4 A GFP-Dgk1p fusion, expressed under the control of the endogenous DGK1 promoter, localized to the ER and nuclear membrane (Fig. 2D).
###end p 36
###begin p 37
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 9 67 9 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>DGK1</italic> opposes the function of <italic>PAH1</italic> at the nuclear membrane.</bold>
###xml 67 68 67 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 221 225 221 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PUS1</italic>
###xml 290 294 290 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 454 463 454 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scale bar</italic>
###xml 473 474 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 488 492 487 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 530 534 529 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 564 568 559 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 579 583 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 589 593 576 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 655 660 638 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 705 714 688 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scale bar</italic>
###xml 9 723 9 705 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="38"><bold><italic>DGK1</italic> opposes the function of <italic>PAH1</italic> at the nuclear membrane.</bold><italic>A</italic>, overexpression of <italic>DGK1</italic> causes nuclear/ER membrane proliferation and nuclear expansion. The RS453 strain expressing the plasmid-borne <italic>SEC63</italic>-GFP and RFP-<italic>PUS1</italic> reporters was transformed with a centromeric plasmid expressing <italic>DGK1</italic> under the control of a galactose-inducible promoter or an empty vector. Cells were grown in galactose-containing medium and visualized by confocal microscopy. <italic>Scale bar</italic> = 5 &#956;m. <italic>B</italic>, deletion of <italic>DGK1</italic> restores normal nuclear structure in <italic>pah1</italic>&#916; cells. Wild-type RS453, <italic>pah1</italic>&#916;, and <italic>pah1</italic>&#916; <italic>dgk1</italic>&#916; cells transformed with a centromeric plasmid expressing <italic>SEC63</italic>-GFP were visualized by confocal microscopy. <italic>Scale bar</italic> = 5 &#956;m.</p>
###xml 9 723 9 705 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="38"><bold><italic>DGK1</italic> opposes the function of <italic>PAH1</italic> at the nuclear membrane.</bold><italic>A</italic>, overexpression of <italic>DGK1</italic> causes nuclear/ER membrane proliferation and nuclear expansion. The RS453 strain expressing the plasmid-borne <italic>SEC63</italic>-GFP and RFP-<italic>PUS1</italic> reporters was transformed with a centromeric plasmid expressing <italic>DGK1</italic> under the control of a galactose-inducible promoter or an empty vector. Cells were grown in galactose-containing medium and visualized by confocal microscopy. <italic>Scale bar</italic> = 5 &#956;m. <italic>B</italic>, deletion of <italic>DGK1</italic> restores normal nuclear structure in <italic>pah1</italic>&#916; cells. Wild-type RS453, <italic>pah1</italic>&#916;, and <italic>pah1</italic>&#916; <italic>dgk1</italic>&#916; cells transformed with a centromeric plasmid expressing <italic>SEC63</italic>-GFP were visualized by confocal microscopy. <italic>Scale bar</italic> = 5 &#956;m.</p></caption>
###xml 723 723 705 705 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0300842590003"/>
###xml 0 723 0 705 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="38"><bold><italic>DGK1</italic> opposes the function of <italic>PAH1</italic> at the nuclear membrane.</bold><italic>A</italic>, overexpression of <italic>DGK1</italic> causes nuclear/ER membrane proliferation and nuclear expansion. The RS453 strain expressing the plasmid-borne <italic>SEC63</italic>-GFP and RFP-<italic>PUS1</italic> reporters was transformed with a centromeric plasmid expressing <italic>DGK1</italic> under the control of a galactose-inducible promoter or an empty vector. Cells were grown in galactose-containing medium and visualized by confocal microscopy. <italic>Scale bar</italic> = 5 &#956;m. <italic>B</italic>, deletion of <italic>DGK1</italic> restores normal nuclear structure in <italic>pah1</italic>&#916; cells. Wild-type RS453, <italic>pah1</italic>&#916;, and <italic>pah1</italic>&#916; <italic>dgk1</italic>&#916; cells transformed with a centromeric plasmid expressing <italic>SEC63</italic>-GFP were visualized by confocal microscopy. <italic>Scale bar</italic> = 5 &#956;m.</p></caption><graphic xlink:href="zbc0300842590003"/></fig>
FIGURE 3.DGK1 opposes the function of PAH1 at the nuclear membrane.A, overexpression of DGK1 causes nuclear/ER membrane proliferation and nuclear expansion. The RS453 strain expressing the plasmid-borne SEC63-GFP and RFP-PUS1 reporters was transformed with a centromeric plasmid expressing DGK1 under the control of a galactose-inducible promoter or an empty vector. Cells were grown in galactose-containing medium and visualized by confocal microscopy. Scale bar = 5 mum. B, deletion of DGK1 restores normal nuclear structure in pah1Delta cells. Wild-type RS453, pah1Delta, and pah1Delta dgk1Delta cells transformed with a centromeric plasmid expressing SEC63-GFP were visualized by confocal microscopy. Scale bar = 5 mum.
###end p 37
###begin p 38
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>DGK1</italic> opposes the function of <italic>PAH1</italic> at the nuclear membrane.</bold>
###xml 58 59 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 212 216 212 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PUS1</italic>
###xml 281 285 281 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 445 454 445 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scale bar</italic>
###xml 464 465 463 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 479 483 478 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 521 525 520 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 555 559 550 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 570 574 561 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 580 584 567 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 646 651 629 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 696 705 679 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scale bar</italic>
DGK1 opposes the function of PAH1 at the nuclear membrane.A, overexpression of DGK1 causes nuclear/ER membrane proliferation and nuclear expansion. The RS453 strain expressing the plasmid-borne SEC63-GFP and RFP-PUS1 reporters was transformed with a centromeric plasmid expressing DGK1 under the control of a galactose-inducible promoter or an empty vector. Cells were grown in galactose-containing medium and visualized by confocal microscopy. Scale bar = 5 mum. B, deletion of DGK1 restores normal nuclear structure in pah1Delta cells. Wild-type RS453, pah1Delta, and pah1Delta dgk1Delta cells transformed with a centromeric plasmid expressing SEC63-GFP were visualized by confocal microscopy. Scale bar = 5 mum.
###end p 38
###begin p 39
###xml 0 64 0 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dgk1p Counteracts the Function of Pah1p by Controlling PA Levels</italic>
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn5">4</xref>
###xml 173 182 173 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NEM1-SPO7</italic>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 320 324 320 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 390 394 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 429 438 429 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NEM1-SPO7</italic>
###xml 522 526 522 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 724 728 724 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 736 737 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 730 737 730 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 770 774 770 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 816 820 816 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 900 904 896 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e.</italic>
###xml 921 925 917 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 981 985 977 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1007 1011 999 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1017 1021 1005 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 1065 1066 1049 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn5">4</xref>
###xml 1147 1152 1131 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 1207 1208 1191 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1201 1208 1185 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>B</italic></xref>
Dgk1p Counteracts the Function of Pah1p by Controlling PA Levels-Cells lacking DGK1 show no apparent growth defects or gross nuclear/ER structure abnormalities.4 Given that NEM1-SPO7 overexpression inhibits nuclear expansion during mitosis (10) and that a previous study reported the appearance of membranous tubules in DGK1-overexpressing cells (19), we first asked whether high levels of DGK1 could rescue the lethality of the NEM1-SPO7 overexpression by promoting nuclear growth. Indeed, wild-type cells overexpressing DGK1 from a galactose-inducible promoter contain enlarged and irregularly shaped nuclei and a striking nuclear/ER membrane proliferation that is reminiscent of that originally observed in cells lacking PAH1 (Fig. 3A). Because the overproduction of DGK1 phenocopies the morphological defects of pah1Delta cells, we next asked whether the complementary possibility would be true, i.e. whether lack of DGK1 would rescue the nuclear expansion that takes place in pah1Delta cells. Although pah1Delta dgk1Delta cells are still temperature-sensitive,4 they have normal nuclear morphology in that the nuclear/ER membrane labeling by SEC63-GFP looks identical to that of wild-type cells (Fig. 3B). Therefore, the function of Dgk1p in the nuclear structure appears to counteract that of Pah1p.
###end p 39
###begin p 40
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 210 214 206 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 261 265 257 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 379 383 371 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 389 393 377 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 493 497 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 527 531 511 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 560 561 540 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 554 561 534 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 601 605 581 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INO1</italic>
###xml 658 660 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 723 724 703 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 717 724 697 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 747 751 727 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 757 761 733 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 900 901 872 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 894 901 866 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 950 951 922 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 944 951 916 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 967 971 939 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1020 1024 988 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 1079 1083 1047 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 1128 1132 1096 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
Because the accumulation of PA contributes to the transcriptional up-regulation of phospholipid biosynthetic genes and to the increased membrane biogenesis in pah1Delta cells, we next asked whether the lack of DGK1 rescues the nuclear membrane proliferation of pah1Delta cells by affecting cellular PA levels. To test this hypothesis, we compared the phospholipid composition of pah1Delta dgk1Delta cells with that of the corresponding single mutants and wild-type strain. Indeed, deletion of DGK1 returns the PA levels of the pah1Delta cells to normal (Fig. 4A). Consistent with this, mRNA levels of INO1 that respond to the intracellular PA concentration (13) are brought back to their respective wild-type values (Fig. 4C). The levels of PE in pah1Delta dgk1Delta are also brought back to normal, whereas the levels of PC are partially corrected. However, the abnormal phosphatidylinositol (Fig. 4A) and major neutral lipid triacylglycerol (Fig. 4B) levels of the pah1Delta mutant are not affected by the deletion of DGK1. Taken together, these data show that the function of DGK1 in the nuclear membrane counteracts that of PAH1 by controlling cellular PA levels.
###end p 40
###begin p 41
###xml 0 41 0 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dgk1p Is a Novel CTP-dependent DAG Kinase</italic>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 109 113 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 511 513 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 515 517 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 543 547 535 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 602 603 594 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 623 627 615 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 655 659 647 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDS1</italic>
###xml 672 673 664 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 693 697 685 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDS1</italic>
###xml 717 721 709 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 739 743 731 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 789 790 781 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn5">4</xref>
###xml 877 884 869 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Dgk1p Is a Novel CTP-dependent DAG Kinase-The fact that the dgk1Delta mutation returns cellular PA levels in pah1Delta cells to normal raised the possibility that the activity of Dgk1p might be directly involved in the synthesis of PA. The cytidylyltransferase domain present in Dgk1p shows significant similarity to the PA cytidylyltransferase Cds1p (also known as CDP-DAG synthase), the enzyme that synthesizes CDP-DAG from CTP and PA. Cds1p can also catalyze the reverse reaction that leads to PA synthesis (20, 21). To investigate whether DGK1 can function as a CDP-DAG synthase, we asked whether (a) overexpression of DGK1 could rescue a conditional CDS1 mutant and (b) overexpression of CDS1 could rescue, like DGK1, the toxicity of PAH1-7P. In both cases, the results were negative.4 Taken together, these data suggest that Dgk1p does not function as a CDP-DAG synthase in vivo.
###end p 41
###begin p 42
###xml 111 135 111 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 546 550 546 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 557 561 553 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 572 576 564 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 582 586 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 611 613 591 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 659 660 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 653 660 633 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 666 670 646 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 715 719 691 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 845 849 817 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 1098 1099 1070 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1092 1099 1064 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 1221 1222 1193 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1215 1222 1187 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 1580 1582 1552 1554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 111 135 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 1017 1035 <span type="species:ncbi:12227">tobacco etch virus</span>
A second reaction that can directly generate PA is the phosphorylation of DAG. Although there is no homolog in Saccharomyces cerevisiae to any of the known ATP-dependent DAG kinases in bacteria or higher eukaryotes (22, 23), a previous report showed that PA is produced from membrane lipids using CTP as a phosphate donor (24). This, coupled with the fact that Dgk1p contains a CTP transferase domain, prompted us to test whether Dgk1p could be a CTP-dependent DAG kinase (25). We measured DAG kinase activity in extracts derived from wild-type, dgk1Delta, pah1Delta, and pah1Delta dgk1Delta cells using [gamma-32P]CTP as a phosphate donor. As shown in Fig. 5A, the dgk1Delta mutation alone and in combination with pah1Delta resulted in a complete loss of the activity catalyzing the formation of PA from DAG and CTP. This result indicated that DGK1 encodes a DAG kinase activity. To confirm this, Dgk1p was partially purified as a PtA-Dgk1p fusion over an IgG-Sepharose column, followed by removal of the PtA tag by tobacco etch virus protease cleavage, and assayed for DAG kinase activity (Fig. 5B). The purified protein catalyzed a dose- and time-dependent phosphorylation of DAG using CTP as a phosphate donor (Fig. 5B). Taken together, these data show that Dgk1p is a novel CTP-dependent DAG kinase enzyme. The fact that Dgk1p uses CTP, rather than ATP, as a phosphate donor, explains why it does not show homology to any of the previously described DAG kinases from other species. The enzymological properties of this novel enzyme are described in the accompanying article (25).
###end p 42
###begin p 43
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INO1</italic>
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 9 79 9 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Deletion of <italic>DGK1</italic> restores normal PA and <italic>INO1</italic> transcript levels in <italic>pah1</italic></bold>
###xml 85 91 81 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">cells.</bold>
###xml 91 92 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 133 137 129 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 144 148 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 159 163 147 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 169 173 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 300 302 280 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 303 304 283 284 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 418 420 397 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 601 603 580 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 768 770 745 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PI</italic>
###xml 794 796 771 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PS</italic>
###xml 818 819 795 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 861 865 838 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 872 876 845 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 887 891 856 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 897 901 862 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 1029 1031 990 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 1146 1148 1106 1108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 1315 1317 1275 1277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 1423 1426 1381 1384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAG</italic>
###xml 1445 1448 1403 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erg</italic>
###xml 1462 1466 1420 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ErgE</italic>
###xml 1486 1488 1444 1446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FA</italic>
###xml 1502 1504 1460 1462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PL</italic>
###xml 1520 1521 1478 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1523 1527 1481 1485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INO1</italic>
###xml 1554 1558 1512 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1565 1569 1519 1523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 1580 1584 1530 1534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1590 1594 1536 1540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 1626 1630 1568 1572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INO1</italic>
###xml 1818 1822 1760 1764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RTG2</italic>
###xml 9 1986 9 1928 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="44"><bold>Deletion of <italic>DGK1</italic> restores normal PA and <italic>INO1</italic> transcript levels in <italic>pah1</italic></bold>&#916; <bold>cells.</bold><italic>A</italic>, phospholipid composition of wild-type, <italic>dgk1</italic>&#916;, <italic>pah1</italic>&#916;, and <italic>pah1</italic>&#916; <italic>dgk1</italic>&#916; cells in the exponential phase of growth. The indicated yeast strains were grown to exponential phase in the presence of <sup>32</sup>P<sub>i</sub> (10 &#956;Ci/ml). Phospholipids were extracted and separated by two-dimensional thin layer chromatography. Images of <sup>32</sup>P-labeled phospholipids were visualized by phosphorimaging and subjected to ImageQuant analysis. The percentages shown for the individual phospholipids were normalized to the total <sup>32</sup>P-labeled chloroform-soluble fraction that included sphingolipids and unidentified phospholipids. Each data point represents the mean &#177; S.D. of three experiments. <italic>PI</italic>, phosphatidylinositol; <italic>PS</italic>, phosphatidylserine. <italic>B</italic>, neutral lipid composition of wild-type, <italic>dgk1</italic>&#916;, <italic>pah1</italic>&#916;, and <italic>pah1</italic>&#916; <italic>dgk1</italic>&#916; cells in the stationary phase of growth. The indicated yeast strains were grown to stationary phase in the presence of [2-<sup>14</sup>C]acetate (1 &#956;Ci/ml). Lipids were extracted and separated by one-dimensional thin layer chromatography. Images of <sup>14</sup>C-labeled lipids were visualized by phosphorimaging and subjected to ImageQuant analysis. The percentages shown for the individual lipids were normalized to the total <sup>14</sup>C-labeled chloroform-soluble fraction. Each data point represents the mean &#177; S.D. of three experiments. <italic>TAG</italic>, triacylglycerol; <italic>Erg</italic>, ergosterol; <italic>ErgE</italic>, ergosterol ester; <italic>FA</italic>, fatty acid; <italic>PL</italic>, phospholipid. <italic>C</italic>, <italic>INO1</italic> mRNA levels of wild-type, <italic>pah1</italic>&#916;, <italic>dgk1</italic>&#916;, and <italic>pah1</italic>&#916; <italic>dgk1</italic>&#916; cells. The mRNA levels of <italic>INO1</italic> were analyzed in the indicated strains grown in YEPD medium by quantitative real-time reverse transcription-PCR. Amplification of each sample was performed in duplicate and normalized to <italic>RTG2</italic>. Values and errors were calculated from three independent experiments. Values are expressed as -fold derepression over the values measured in the wild-type strain.</p>
###xml 9 1986 9 1928 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="44"><bold>Deletion of <italic>DGK1</italic> restores normal PA and <italic>INO1</italic> transcript levels in <italic>pah1</italic></bold>&#916; <bold>cells.</bold><italic>A</italic>, phospholipid composition of wild-type, <italic>dgk1</italic>&#916;, <italic>pah1</italic>&#916;, and <italic>pah1</italic>&#916; <italic>dgk1</italic>&#916; cells in the exponential phase of growth. The indicated yeast strains were grown to exponential phase in the presence of <sup>32</sup>P<sub>i</sub> (10 &#956;Ci/ml). Phospholipids were extracted and separated by two-dimensional thin layer chromatography. Images of <sup>32</sup>P-labeled phospholipids were visualized by phosphorimaging and subjected to ImageQuant analysis. The percentages shown for the individual phospholipids were normalized to the total <sup>32</sup>P-labeled chloroform-soluble fraction that included sphingolipids and unidentified phospholipids. Each data point represents the mean &#177; S.D. of three experiments. <italic>PI</italic>, phosphatidylinositol; <italic>PS</italic>, phosphatidylserine. <italic>B</italic>, neutral lipid composition of wild-type, <italic>dgk1</italic>&#916;, <italic>pah1</italic>&#916;, and <italic>pah1</italic>&#916; <italic>dgk1</italic>&#916; cells in the stationary phase of growth. The indicated yeast strains were grown to stationary phase in the presence of [2-<sup>14</sup>C]acetate (1 &#956;Ci/ml). Lipids were extracted and separated by one-dimensional thin layer chromatography. Images of <sup>14</sup>C-labeled lipids were visualized by phosphorimaging and subjected to ImageQuant analysis. The percentages shown for the individual lipids were normalized to the total <sup>14</sup>C-labeled chloroform-soluble fraction. Each data point represents the mean &#177; S.D. of three experiments. <italic>TAG</italic>, triacylglycerol; <italic>Erg</italic>, ergosterol; <italic>ErgE</italic>, ergosterol ester; <italic>FA</italic>, fatty acid; <italic>PL</italic>, phospholipid. <italic>C</italic>, <italic>INO1</italic> mRNA levels of wild-type, <italic>pah1</italic>&#916;, <italic>dgk1</italic>&#916;, and <italic>pah1</italic>&#916; <italic>dgk1</italic>&#916; cells. The mRNA levels of <italic>INO1</italic> were analyzed in the indicated strains grown in YEPD medium by quantitative real-time reverse transcription-PCR. Amplification of each sample was performed in duplicate and normalized to <italic>RTG2</italic>. Values and errors were calculated from three independent experiments. Values are expressed as -fold derepression over the values measured in the wild-type strain.</p></caption>
###xml 1986 1986 1928 1928 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0300842590004"/>
###xml 0 1986 0 1928 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="44"><bold>Deletion of <italic>DGK1</italic> restores normal PA and <italic>INO1</italic> transcript levels in <italic>pah1</italic></bold>&#916; <bold>cells.</bold><italic>A</italic>, phospholipid composition of wild-type, <italic>dgk1</italic>&#916;, <italic>pah1</italic>&#916;, and <italic>pah1</italic>&#916; <italic>dgk1</italic>&#916; cells in the exponential phase of growth. The indicated yeast strains were grown to exponential phase in the presence of <sup>32</sup>P<sub>i</sub> (10 &#956;Ci/ml). Phospholipids were extracted and separated by two-dimensional thin layer chromatography. Images of <sup>32</sup>P-labeled phospholipids were visualized by phosphorimaging and subjected to ImageQuant analysis. The percentages shown for the individual phospholipids were normalized to the total <sup>32</sup>P-labeled chloroform-soluble fraction that included sphingolipids and unidentified phospholipids. Each data point represents the mean &#177; S.D. of three experiments. <italic>PI</italic>, phosphatidylinositol; <italic>PS</italic>, phosphatidylserine. <italic>B</italic>, neutral lipid composition of wild-type, <italic>dgk1</italic>&#916;, <italic>pah1</italic>&#916;, and <italic>pah1</italic>&#916; <italic>dgk1</italic>&#916; cells in the stationary phase of growth. The indicated yeast strains were grown to stationary phase in the presence of [2-<sup>14</sup>C]acetate (1 &#956;Ci/ml). Lipids were extracted and separated by one-dimensional thin layer chromatography. Images of <sup>14</sup>C-labeled lipids were visualized by phosphorimaging and subjected to ImageQuant analysis. The percentages shown for the individual lipids were normalized to the total <sup>14</sup>C-labeled chloroform-soluble fraction. Each data point represents the mean &#177; S.D. of three experiments. <italic>TAG</italic>, triacylglycerol; <italic>Erg</italic>, ergosterol; <italic>ErgE</italic>, ergosterol ester; <italic>FA</italic>, fatty acid; <italic>PL</italic>, phospholipid. <italic>C</italic>, <italic>INO1</italic> mRNA levels of wild-type, <italic>pah1</italic>&#916;, <italic>dgk1</italic>&#916;, and <italic>pah1</italic>&#916; <italic>dgk1</italic>&#916; cells. The mRNA levels of <italic>INO1</italic> were analyzed in the indicated strains grown in YEPD medium by quantitative real-time reverse transcription-PCR. Amplification of each sample was performed in duplicate and normalized to <italic>RTG2</italic>. Values and errors were calculated from three independent experiments. Values are expressed as -fold derepression over the values measured in the wild-type strain.</p></caption><graphic xlink:href="zbc0300842590004"/></fig>
###xml 235 240 <span type="species:ncbi:4932">yeast</span>
###xml 962 967 <span type="species:ncbi:4932">yeast</span>
FIGURE 4.Deletion of DGK1 restores normal PA and INO1 transcript levels in pah1Delta cells.A, phospholipid composition of wild-type, dgk1Delta, pah1Delta, and pah1Delta dgk1Delta cells in the exponential phase of growth. The indicated yeast strains were grown to exponential phase in the presence of 32Pi (10 muCi/ml). Phospholipids were extracted and separated by two-dimensional thin layer chromatography. Images of 32P-labeled phospholipids were visualized by phosphorimaging and subjected to ImageQuant analysis. The percentages shown for the individual phospholipids were normalized to the total 32P-labeled chloroform-soluble fraction that included sphingolipids and unidentified phospholipids. Each data point represents the mean +/- S.D. of three experiments. PI, phosphatidylinositol; PS, phosphatidylserine. B, neutral lipid composition of wild-type, dgk1Delta, pah1Delta, and pah1Delta dgk1Delta cells in the stationary phase of growth. The indicated yeast strains were grown to stationary phase in the presence of [2-14C]acetate (1 muCi/ml). Lipids were extracted and separated by one-dimensional thin layer chromatography. Images of 14C-labeled lipids were visualized by phosphorimaging and subjected to ImageQuant analysis. The percentages shown for the individual lipids were normalized to the total 14C-labeled chloroform-soluble fraction. Each data point represents the mean +/- S.D. of three experiments. TAG, triacylglycerol; Erg, ergosterol; ErgE, ergosterol ester; FA, fatty acid; PL, phospholipid. C, INO1 mRNA levels of wild-type, pah1Delta, dgk1Delta, and pah1Delta dgk1Delta cells. The mRNA levels of INO1 were analyzed in the indicated strains grown in YEPD medium by quantitative real-time reverse transcription-PCR. Amplification of each sample was performed in duplicate and normalized to RTG2. Values and errors were calculated from three independent experiments. Values are expressed as -fold derepression over the values measured in the wild-type strain.
###end p 43
###begin p 44
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INO1</italic>
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 0 70 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Deletion of <italic>DGK1</italic> restores normal PA and <italic>INO1</italic> transcript levels in <italic>pah1</italic></bold>
###xml 76 82 72 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">cells.</bold>
###xml 82 83 78 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 124 128 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 135 139 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 150 154 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 160 164 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 291 293 271 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 294 295 274 275 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 409 411 388 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 592 594 571 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 759 761 736 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PI</italic>
###xml 785 787 762 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PS</italic>
###xml 809 810 786 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 852 856 829 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 863 867 836 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 878 882 847 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 888 892 853 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 1020 1022 981 983 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 1137 1139 1097 1099 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 1306 1308 1266 1268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 1414 1417 1372 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAG</italic>
###xml 1436 1439 1394 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erg</italic>
###xml 1453 1457 1411 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ErgE</italic>
###xml 1477 1479 1435 1437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FA</italic>
###xml 1493 1495 1451 1453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PL</italic>
###xml 1511 1512 1469 1470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1514 1518 1472 1476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INO1</italic>
###xml 1545 1549 1503 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1556 1560 1510 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 1571 1575 1521 1525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1581 1585 1527 1531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 1617 1621 1559 1563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INO1</italic>
###xml 1809 1813 1751 1755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RTG2</italic>
###xml 226 231 <span type="species:ncbi:4932">yeast</span>
###xml 953 958 <span type="species:ncbi:4932">yeast</span>
Deletion of DGK1 restores normal PA and INO1 transcript levels in pah1Delta cells.A, phospholipid composition of wild-type, dgk1Delta, pah1Delta, and pah1Delta dgk1Delta cells in the exponential phase of growth. The indicated yeast strains were grown to exponential phase in the presence of 32Pi (10 muCi/ml). Phospholipids were extracted and separated by two-dimensional thin layer chromatography. Images of 32P-labeled phospholipids were visualized by phosphorimaging and subjected to ImageQuant analysis. The percentages shown for the individual phospholipids were normalized to the total 32P-labeled chloroform-soluble fraction that included sphingolipids and unidentified phospholipids. Each data point represents the mean +/- S.D. of three experiments. PI, phosphatidylinositol; PS, phosphatidylserine. B, neutral lipid composition of wild-type, dgk1Delta, pah1Delta, and pah1Delta dgk1Delta cells in the stationary phase of growth. The indicated yeast strains were grown to stationary phase in the presence of [2-14C]acetate (1 muCi/ml). Lipids were extracted and separated by one-dimensional thin layer chromatography. Images of 14C-labeled lipids were visualized by phosphorimaging and subjected to ImageQuant analysis. The percentages shown for the individual lipids were normalized to the total 14C-labeled chloroform-soluble fraction. Each data point represents the mean +/- S.D. of three experiments. TAG, triacylglycerol; Erg, ergosterol; ErgE, ergosterol ester; FA, fatty acid; PL, phospholipid. C, INO1 mRNA levels of wild-type, pah1Delta, dgk1Delta, and pah1Delta dgk1Delta cells. The mRNA levels of INO1 were analyzed in the indicated strains grown in YEPD medium by quantitative real-time reverse transcription-PCR. Amplification of each sample was performed in duplicate and normalized to RTG2. Values and errors were calculated from three independent experiments. Values are expressed as -fold derepression over the values measured in the wild-type strain.
###end p 44
###begin p 45
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 5.</label>
###xml 9 51 9 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Dgk1p is a novel CTP-dependent DAG kinase.</bold>
###xml 51 52 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 163 167 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 174 178 166 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 189 193 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 199 203 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 344 354 323 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Left panel</italic>
###xml 360 362 339 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 557 568 536 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Right panel</italic>
###xml 574 576 553 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 763 764 740 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 903 913 880 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 953 964 930 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
###xml 9 966 9 943 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="46"><bold>Dgk1p is a novel CTP-dependent DAG kinase.</bold><italic>A</italic>, the <italic>dgk1</italic>&#916; mutation abolishes diacylglycerol kinase activity. Cell extracts were prepared from wild-type, <italic>dgk1</italic>&#916;, <italic>pah1</italic>&#916;, and <italic>pah1</italic>&#916; <italic>dgk1</italic>&#916; cells at the exponential phase of growth, and 50 &#956;g of protein from each cell extract was assayed for diacylglycerol kinase activity. <italic>Left panel</italic>, the <sup>32</sup>P-labeled reaction product was extracted with chloroform, separated by thin layer chromatography using a solvent system of chloroform/methanol/water (65:25:4), and visualized by phosphorimaging. <italic>Right panel</italic>, the <sup>32</sup>P-labeled reaction product was extracted with chloroform and subjected to liquid scintillation counting. Each data point represents the mean &#177; S.D. of triplicate enzyme determinations. <italic>B</italic>, Dgk1p exhibits DAG kinase activity. The DAG kinase activity of partially purified Dgk1p was measured with the indicated protein content (<italic>left panel</italic>) and for the indicated time intervals (<italic>right panel</italic>).</p>
###xml 9 966 9 943 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="46"><bold>Dgk1p is a novel CTP-dependent DAG kinase.</bold><italic>A</italic>, the <italic>dgk1</italic>&#916; mutation abolishes diacylglycerol kinase activity. Cell extracts were prepared from wild-type, <italic>dgk1</italic>&#916;, <italic>pah1</italic>&#916;, and <italic>pah1</italic>&#916; <italic>dgk1</italic>&#916; cells at the exponential phase of growth, and 50 &#956;g of protein from each cell extract was assayed for diacylglycerol kinase activity. <italic>Left panel</italic>, the <sup>32</sup>P-labeled reaction product was extracted with chloroform, separated by thin layer chromatography using a solvent system of chloroform/methanol/water (65:25:4), and visualized by phosphorimaging. <italic>Right panel</italic>, the <sup>32</sup>P-labeled reaction product was extracted with chloroform and subjected to liquid scintillation counting. Each data point represents the mean &#177; S.D. of triplicate enzyme determinations. <italic>B</italic>, Dgk1p exhibits DAG kinase activity. The DAG kinase activity of partially purified Dgk1p was measured with the indicated protein content (<italic>left panel</italic>) and for the indicated time intervals (<italic>right panel</italic>).</p></caption>
###xml 966 966 943 943 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0300842590005"/>
###xml 0 966 0 943 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig5"><label>FIGURE 5.</label><caption><p textid="46"><bold>Dgk1p is a novel CTP-dependent DAG kinase.</bold><italic>A</italic>, the <italic>dgk1</italic>&#916; mutation abolishes diacylglycerol kinase activity. Cell extracts were prepared from wild-type, <italic>dgk1</italic>&#916;, <italic>pah1</italic>&#916;, and <italic>pah1</italic>&#916; <italic>dgk1</italic>&#916; cells at the exponential phase of growth, and 50 &#956;g of protein from each cell extract was assayed for diacylglycerol kinase activity. <italic>Left panel</italic>, the <sup>32</sup>P-labeled reaction product was extracted with chloroform, separated by thin layer chromatography using a solvent system of chloroform/methanol/water (65:25:4), and visualized by phosphorimaging. <italic>Right panel</italic>, the <sup>32</sup>P-labeled reaction product was extracted with chloroform and subjected to liquid scintillation counting. Each data point represents the mean &#177; S.D. of triplicate enzyme determinations. <italic>B</italic>, Dgk1p exhibits DAG kinase activity. The DAG kinase activity of partially purified Dgk1p was measured with the indicated protein content (<italic>left panel</italic>) and for the indicated time intervals (<italic>right panel</italic>).</p></caption><graphic xlink:href="zbc0300842590005"/></fig>
FIGURE 5.Dgk1p is a novel CTP-dependent DAG kinase.A, the dgk1Delta mutation abolishes diacylglycerol kinase activity. Cell extracts were prepared from wild-type, dgk1Delta, pah1Delta, and pah1Delta dgk1Delta cells at the exponential phase of growth, and 50 mug of protein from each cell extract was assayed for diacylglycerol kinase activity. Left panel, the 32P-labeled reaction product was extracted with chloroform, separated by thin layer chromatography using a solvent system of chloroform/methanol/water (65:25:4), and visualized by phosphorimaging. Right panel, the 32P-labeled reaction product was extracted with chloroform and subjected to liquid scintillation counting. Each data point represents the mean +/- S.D. of triplicate enzyme determinations. B, Dgk1p exhibits DAG kinase activity. The DAG kinase activity of partially purified Dgk1p was measured with the indicated protein content (left panel) and for the indicated time intervals (right panel).
###end p 45
###begin p 46
###xml 0 42 0 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Dgk1p is a novel CTP-dependent DAG kinase.</bold>
###xml 42 43 42 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 154 158 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 165 169 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 180 184 168 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 190 194 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 335 345 314 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Left panel</italic>
###xml 351 353 330 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 548 559 527 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Right panel</italic>
###xml 565 567 544 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 754 755 731 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 894 904 871 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 944 955 921 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
Dgk1p is a novel CTP-dependent DAG kinase.A, the dgk1Delta mutation abolishes diacylglycerol kinase activity. Cell extracts were prepared from wild-type, dgk1Delta, pah1Delta, and pah1Delta dgk1Delta cells at the exponential phase of growth, and 50 mug of protein from each cell extract was assayed for diacylglycerol kinase activity. Left panel, the 32P-labeled reaction product was extracted with chloroform, separated by thin layer chromatography using a solvent system of chloroform/methanol/water (65:25:4), and visualized by phosphorimaging. Right panel, the 32P-labeled reaction product was extracted with chloroform and subjected to liquid scintillation counting. Each data point represents the mean +/- S.D. of triplicate enzyme determinations. B, Dgk1p exhibits DAG kinase activity. The DAG kinase activity of partially purified Dgk1p was measured with the indicated protein content (left panel) and for the indicated time intervals (right panel).
###end p 46
###begin p 47
###xml 0 52 0 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dgk1p-derived PA Accumulates on the Nuclear Membrane</italic>
###xml 455 458 455 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink">177</sup>
###xml 563 564 563 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 557 564 557 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 569 573 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 606 610 602 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 664 668 660 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 738 739 734 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 732 739 728 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>B</italic></xref>
###xml 763 767 759 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 842 843 838 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 836 843 832 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>C</italic></xref>
Dgk1p-derived PA Accumulates on the Nuclear Membrane-Next, we asked whether the DAG kinase activity of Dgk1p is responsible for nuclear/ER membrane growth. The CTP transferase domain of Dgk1p exhibits significant similarity to the corresponding domain of cytidylyltransferases, presumably because both need to bind to CTP for catalysis. Multiple sequence alignment of Dgk1p with cytidylyltransferases from many species identified an aspartate residue (Asp177) within its catalytic domain that is essentially conserved in all cytidylyltransferases examined (Fig. 6A). A dgk1Delta strain expressing a mutant DGK1 allele in which this residue was changed to alanine (DGK1(D177A)) did not display any CTP-dependent DAG kinase activity (Fig. 6B) and, unlike wild-type DGK1, did not trigger nuclear/ER membrane expansion in galactose medium (Fig. 6C). Therefore, the DAG kinase activity of Dgk1p is responsible for nuclear membrane expansion.
###end p 47
###begin p 48
###xml 310 311 310 311 <underline xmlns:xlink="http://www.w3.org/1999/xlink">t</underline>
###xml 326 327 326 327 <underline xmlns:xlink="http://www.w3.org/1999/xlink">s</underline>
###xml 334 335 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 334 335 334 335 <underline xmlns:xlink="http://www.w3.org/1999/xlink"><italic>N</italic></underline>
###xml 368 369 368 369 <underline xmlns:xlink="http://www.w3.org/1999/xlink">a</underline>
###xml 387 389 387 389 <underline xmlns:xlink="http://www.w3.org/1999/xlink">re</underline>
###xml 480 487 480 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 663 667 663 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 668 670 668 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10</italic>
###xml 678 682 678 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 854 855 854 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 848 855 848 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7<italic>A</italic></xref>
###xml 878 881 878 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL</italic>
###xml 882 886 882 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 982 983 982 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 976 983 976 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7<italic>B</italic></xref>
###xml 1200 1201 1200 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1194 1201 1194 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7<italic>B</italic></xref>
###xml 1306 1308 1306 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 1385 1386 1385 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn5">4</xref>
###xml 540 545 <span type="species:ncbi:4932">yeast</span>
###xml 1299 1304 <span type="species:ncbi:4932">yeast</span>
If the DAG kinase activity of Dgk1p causes nuclear expansion, then one would expect that PA levels in intracellular membranes would rise following the induction of Dgk1p. To visualize the intracellular location of PA accumulation, we followed the distribution of a GFP fusion of a short domain of the t-SNARE (target membrane soluble N-ethylmaleimide-sensitive factor attachment protein receptor) Spo20p (GFP-Spo20p-(51-91)). This GFP fusion is responsive to changes in PA levels in vivo and has been used previously as a PA sensor in both yeast (26) and mammalian (27) cells. Cells expressing GFP-Spo20p-(51-91) were transformed with either an empty vector or a GAL1/10-driven DGK1 plasmid and transferred into galactose-containing medium. Consistent with previous data (26), in control cells, GFP-Spo20p-(51-91) was found at the plasma membrane (Fig. 7A). When cells carrying GAL-DGK1 were transferred into galactose medium, the PA sensor relocalized to internal membranes (Fig. 7B). Interestingly, in the majority of these cells (79% of the cells with internal membrane staining), the PA-enriched membranes formed around the irregularly shaped nucleus and often extended into the cytoplasm (Fig. 7B). Overexpression of bacterial Dgk1p, which has been shown to relocalize to internal membranes in yeast (26), resulted in a similar relocation of the PA sensor to the nuclear membrane.4 Taken together, these results indicate that Dgk1p-produced PA accumulates on intracellular membranes around the nucleus.
###end p 48
###begin p 49
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 6.</label>
###xml 9 85 9 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The DAG kinase activity of Dgk1p is required for nuclear membrane expansion.</bold>
###xml 85 86 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 260 265 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrow</italic>
###xml 309 310 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 316 320 316 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 366 370 366 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 467 471 463 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 475 479 471 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 512 516 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 517 519 513 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10</italic>
###xml 682 683 678 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 685 689 681 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 769 774 765 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 831 835 827 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 839 843 835 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 866 867 862 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 9 962 9 958 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="50"><bold>The DAG kinase activity of Dgk1p is required for nuclear membrane expansion.</bold><italic>A</italic>, multiple sequence alignment of Dgk1p (residues 162-182) with cytidylyltransferases from the indicated species. The first residue of each sequence segment is indicated. The <italic>arrow</italic> points to the conserved aspartate residue. <italic>B</italic>, the <italic>DGK1</italic>(D177A) mutant lacks DAG kinase activity. The <italic>dgk1</italic>&#916; strain was transformed with an empty centromeric plasmid or with the same plasmid carrying <italic>DGK1</italic> or <italic>DGK1</italic>(D177A) under the control of the <italic>GAL1</italic>/<italic>10</italic> promoter. Cell extracts from the corresponding strains were assayed for diacylglycerol kinase activity. Values and errors were calculated from three experiments. <italic>C</italic>, <italic>DGK1</italic>(D177A) does not promote nuclear membrane growth. The RS453 strain expressing a <italic>SEC63</italic>-GFP fusion was transformed with the galactose-inducible <italic>DGK1</italic> or <italic>DGK1</italic>(D177A) construct from <italic>B</italic>, grown to early logarithmic phase in galactose-containing medium, and inspected by microscopy.</p>
###xml 9 962 9 958 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="50"><bold>The DAG kinase activity of Dgk1p is required for nuclear membrane expansion.</bold><italic>A</italic>, multiple sequence alignment of Dgk1p (residues 162-182) with cytidylyltransferases from the indicated species. The first residue of each sequence segment is indicated. The <italic>arrow</italic> points to the conserved aspartate residue. <italic>B</italic>, the <italic>DGK1</italic>(D177A) mutant lacks DAG kinase activity. The <italic>dgk1</italic>&#916; strain was transformed with an empty centromeric plasmid or with the same plasmid carrying <italic>DGK1</italic> or <italic>DGK1</italic>(D177A) under the control of the <italic>GAL1</italic>/<italic>10</italic> promoter. Cell extracts from the corresponding strains were assayed for diacylglycerol kinase activity. Values and errors were calculated from three experiments. <italic>C</italic>, <italic>DGK1</italic>(D177A) does not promote nuclear membrane growth. The RS453 strain expressing a <italic>SEC63</italic>-GFP fusion was transformed with the galactose-inducible <italic>DGK1</italic> or <italic>DGK1</italic>(D177A) construct from <italic>B</italic>, grown to early logarithmic phase in galactose-containing medium, and inspected by microscopy.</p></caption>
###xml 962 962 958 958 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0300842590006"/>
###xml 0 962 0 958 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig6"><label>FIGURE 6.</label><caption><p textid="50"><bold>The DAG kinase activity of Dgk1p is required for nuclear membrane expansion.</bold><italic>A</italic>, multiple sequence alignment of Dgk1p (residues 162-182) with cytidylyltransferases from the indicated species. The first residue of each sequence segment is indicated. The <italic>arrow</italic> points to the conserved aspartate residue. <italic>B</italic>, the <italic>DGK1</italic>(D177A) mutant lacks DAG kinase activity. The <italic>dgk1</italic>&#916; strain was transformed with an empty centromeric plasmid or with the same plasmid carrying <italic>DGK1</italic> or <italic>DGK1</italic>(D177A) under the control of the <italic>GAL1</italic>/<italic>10</italic> promoter. Cell extracts from the corresponding strains were assayed for diacylglycerol kinase activity. Values and errors were calculated from three experiments. <italic>C</italic>, <italic>DGK1</italic>(D177A) does not promote nuclear membrane growth. The RS453 strain expressing a <italic>SEC63</italic>-GFP fusion was transformed with the galactose-inducible <italic>DGK1</italic> or <italic>DGK1</italic>(D177A) construct from <italic>B</italic>, grown to early logarithmic phase in galactose-containing medium, and inspected by microscopy.</p></caption><graphic xlink:href="zbc0300842590006"/></fig>
FIGURE 6.The DAG kinase activity of Dgk1p is required for nuclear membrane expansion.A, multiple sequence alignment of Dgk1p (residues 162-182) with cytidylyltransferases from the indicated species. The first residue of each sequence segment is indicated. The arrow points to the conserved aspartate residue. B, the DGK1(D177A) mutant lacks DAG kinase activity. The dgk1Delta strain was transformed with an empty centromeric plasmid or with the same plasmid carrying DGK1 or DGK1(D177A) under the control of the GAL1/10 promoter. Cell extracts from the corresponding strains were assayed for diacylglycerol kinase activity. Values and errors were calculated from three experiments. C, DGK1(D177A) does not promote nuclear membrane growth. The RS453 strain expressing a SEC63-GFP fusion was transformed with the galactose-inducible DGK1 or DGK1(D177A) construct from B, grown to early logarithmic phase in galactose-containing medium, and inspected by microscopy.
###end p 49
###begin p 50
###xml 0 76 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The DAG kinase activity of Dgk1p is required for nuclear membrane expansion.</bold>
###xml 76 77 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 251 256 251 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrow</italic>
###xml 300 301 300 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 307 311 307 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 357 361 357 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 458 462 454 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 466 470 462 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 503 507 499 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 508 510 504 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10</italic>
###xml 673 674 669 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 676 680 672 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 760 765 756 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 822 826 818 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 830 834 826 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 857 858 853 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
The DAG kinase activity of Dgk1p is required for nuclear membrane expansion.A, multiple sequence alignment of Dgk1p (residues 162-182) with cytidylyltransferases from the indicated species. The first residue of each sequence segment is indicated. The arrow points to the conserved aspartate residue. B, the DGK1(D177A) mutant lacks DAG kinase activity. The dgk1Delta strain was transformed with an empty centromeric plasmid or with the same plasmid carrying DGK1 or DGK1(D177A) under the control of the GAL1/10 promoter. Cell extracts from the corresponding strains were assayed for diacylglycerol kinase activity. Values and errors were calculated from three experiments. C, DGK1(D177A) does not promote nuclear membrane growth. The RS453 strain expressing a SEC63-GFP fusion was transformed with the galactose-inducible DGK1 or DGK1(D177A) construct from B, grown to early logarithmic phase in galactose-containing medium, and inspected by microscopy.
###end p 50
###begin p 51
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 7.</label>
###xml 9 100 9 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Overexpression of Dgk1p causes relocation of a PA-binding reporter at the nuclear membrane.</bold>
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PUS1</italic>
###xml 165 170 165 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPO20</italic>
###xml 224 225 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 255 259 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 261 262 260 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 385 394 384 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scale bar</italic>
###xml 9 403 9 401 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="52"><bold>Overexpression of Dgk1p causes relocation of a PA-binding reporter at the nuclear membrane.</bold> The RS453 strain expressing the mCherry-<italic>PUS1</italic> fusion and the GFP-<italic>SPO20</italic>-(51-91) reporter was transformed with a 2 &#956; vector (<italic>A</italic>) or the same vector carrying <italic>DGK1</italic> (<italic>B</italic>). Cells were grown in raffinose, transferred into galactose-containing medium for 6 h, and viewed by confocal microscopy. <italic>Scale bar</italic> = 5 &#956;m.</p>
###xml 9 403 9 401 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="52"><bold>Overexpression of Dgk1p causes relocation of a PA-binding reporter at the nuclear membrane.</bold> The RS453 strain expressing the mCherry-<italic>PUS1</italic> fusion and the GFP-<italic>SPO20</italic>-(51-91) reporter was transformed with a 2 &#956; vector (<italic>A</italic>) or the same vector carrying <italic>DGK1</italic> (<italic>B</italic>). Cells were grown in raffinose, transferred into galactose-containing medium for 6 h, and viewed by confocal microscopy. <italic>Scale bar</italic> = 5 &#956;m.</p></caption>
###xml 403 403 401 401 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0300842590007"/>
###xml 0 403 0 401 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig7"><label>FIGURE 7.</label><caption><p textid="52"><bold>Overexpression of Dgk1p causes relocation of a PA-binding reporter at the nuclear membrane.</bold> The RS453 strain expressing the mCherry-<italic>PUS1</italic> fusion and the GFP-<italic>SPO20</italic>-(51-91) reporter was transformed with a 2 &#956; vector (<italic>A</italic>) or the same vector carrying <italic>DGK1</italic> (<italic>B</italic>). Cells were grown in raffinose, transferred into galactose-containing medium for 6 h, and viewed by confocal microscopy. <italic>Scale bar</italic> = 5 &#956;m.</p></caption><graphic xlink:href="zbc0300842590007"/></fig>
FIGURE 7.Overexpression of Dgk1p causes relocation of a PA-binding reporter at the nuclear membrane. The RS453 strain expressing the mCherry-PUS1 fusion and the GFP-SPO20-(51-91) reporter was transformed with a 2 mu vector (A) or the same vector carrying DGK1 (B). Cells were grown in raffinose, transferred into galactose-containing medium for 6 h, and viewed by confocal microscopy. Scale bar = 5 mum.
###end p 51
###begin p 52
###xml 0 91 0 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Overexpression of Dgk1p causes relocation of a PA-binding reporter at the nuclear membrane.</bold>
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PUS1</italic>
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPO20</italic>
###xml 215 216 214 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 246 250 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 252 253 251 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 376 385 375 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scale bar</italic>
Overexpression of Dgk1p causes relocation of a PA-binding reporter at the nuclear membrane. The RS453 strain expressing the mCherry-PUS1 fusion and the GFP-SPO20-(51-91) reporter was transformed with a 2 mu vector (A) or the same vector carrying DGK1 (B). Cells were grown in raffinose, transferred into galactose-containing medium for 6 h, and viewed by confocal microscopy. Scale bar = 5 mum.
###end p 52
###begin p 53
###xml 0 75 0 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dgk1p Regulates Nuclear Membrane but Not Cortical ER Membrane Proliferation</italic>
###xml 195 199 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">viz.</italic>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref30">30</xref>
###xml 651 654 651 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL</italic>
###xml 655 659 655 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 708 709 708 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 702 709 702 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8<italic>A</italic></xref>
###xml 761 762 761 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn5">4</xref>
###xml 920 921 920 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 914 921 914 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8<italic>B</italic></xref>
###xml 1176 1177 1176 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1170 1177 1170 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8<italic>C</italic></xref>
###xml 1179 1191 1179 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panels</italic>
###xml 1208 1220 1208 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panels</italic>
Dgk1p Regulates Nuclear Membrane but Not Cortical ER Membrane Proliferation-We next asked whether the high levels of PA produced by Dgk1p cause membrane proliferation of both ER subcompartments, viz. the cortical ER and the perinuclear ER or nuclear membrane. To address this question, we used a GFP fusion of Rtn2p, a member of the reticulon family of integral membrane proteins that, unlike other ER proteins like Sec63p, localize exclusively to the cortical ER (28, 29). To label the nuclear membrane, we expressed a GFP fusion of Heh2p, an integral inner nuclear membrane protein that does not diffuse to the cortical ER (30). When cells carrying GAL-DGK1 were grown under non-inducing conditions (Fig. 8A), neither the nuclear nor cortical ER was affected.4 Induction of Dgk1p production for 5 h led to irregularly shaped nuclei, often containing one nuclear membrane projection extending into the cytoplasm (Fig. 8B). After 9 h, nuclear expansion was more evident, leading to many cells with two expanded interconnected nuclear compartments. Interestingly, at both time points, no apparent proliferation of the cortical ER membrane was seen. The overall cortical (Fig. 8C, upper panels) and reticular (lower panels) membrane staining of Rtn2p-GFP was not significantly altered in the Dgk1p-overexpressing cells compared with the control cells. Therefore, elevated PA levels, generated by the overexpression of Dgk1p, causes proliferation of the membrane of the nuclear but not cortical ER.
###end p 53
###begin p 54
###xml 0 66 0 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lack of Biosynthetic PA Enzymes Restores Nuclear Structure in pah1</italic>
###xml 72 77 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cells</italic>
###xml 153 157 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 163 167 155 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 245 252 233 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo</italic>
###xml 314 318 302 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 403 407 387 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAT1</italic>
###xml 412 416 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAT2</italic>
###xml 474 476 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 493 494 477 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 487 494 471 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 504 508 488 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 526 530 506 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 536 540 512 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gat2</italic>
###xml 581 585 553 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 632 633 594 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 626 633 588 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9<italic>A</italic></xref>
###xml 708 712 670 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INO1</italic>
###xml 779 780 741 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 773 780 735 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9<italic>B</italic></xref>
###xml 983 984 945 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 977 984 939 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9<italic>C</italic></xref>
###xml 987 989 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 1026 1030 988 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1110 1114 1068 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1133 1134 1087 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1127 1134 1081 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9<italic>D</italic></xref>
###xml 1266 1270 1220 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1407 1411 1357 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1417 1421 1363 1367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">psd1</italic>
###xml 1435 1439 1377 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1445 1449 1383 1387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cho2</italic>
###xml 1459 1463 1393 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1469 1473 1399 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">opi3</italic>
###xml 1483 1487 1409 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1533 1537 1455 1459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1543 1547 1461 1465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">psd1</italic>
###xml 1598 1599 1512 1513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1592 1599 1506 1513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9<italic>E</italic></xref>
###xml 1678 1682 1592 1596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">psd1</italic>
###xml 1709 1713 1619 1623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1766 1770 1672 1676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1776 1780 1678 1682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gat2</italic>
###xml 1799 1803 1697 1701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1809 1813 1703 1707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cho2</italic>
###xml 1823 1827 1713 1717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1833 1837 1719 1723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">opi3</italic>
###xml 1883 1884 1765 1766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1877 1884 1759 1766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9<italic>E</italic></xref>
###xml 1916 1917 1798 1799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn5">4</xref>
###xml 2036 2041 <span type="species:ncbi:4932">yeast</span>
Lack of Biosynthetic PA Enzymes Restores Nuclear Structure in pah1Delta Cells-If the decrease in PA is responsible for restoring a normal nucleus in the pah1Delta dgk1Delta mutant, then other mutations that are known to decrease the rate of the de novo synthesis of PA should have a similar compensatory effect in pah1Delta cells. To test this hypothesis, we deleted the redundant acyltransferase genes GAT1 and GAT2, previously shown to be required for PA production (Ref. 31; see also Fig. 1A), in the pah1Delta mutant. The pah1Delta gat2Delta double mutant grew better than the pah1Delta mutant at both 30 and 37 degreesC (Fig. 9A) and exhibited a >50% decrease in the transcriptional derepression of the INO1 gene as measured by quantitative reverse transcription-PCR (Fig. 9B). This epistatic effect is due to the lack of Gat2p enzymatic activity, required for PA production, because it can be reproduced using a mutant (G253L) that is predicted to be catalytically dead (Fig. 9C) (32). Notably, the nuclear structure in pah1Delta cells lacking Gat2p activity was significantly improved compared with the pah1Delta cells (Fig. 9D). Therefore, inhibition of upstream steps that reduce PA synthesis is sufficient to decrease the membrane proliferation defects of pah1Delta cells. We next analyzed the effect of inhibiting steps downstream of the PA phosphatase reaction, leading to the production of PE (pah1Delta psd1Delta) or PC (pah1Delta cho2Delta and pah1Delta opi3Delta) in pah1Delta cells. Interestingly, we found that the pah1Delta psd1Delta double mutant is synthetically lethal (Fig. 9E), possibly because of the simultaneous inhibition of both the CDP-DAG (due to psd1Delta) and Kennedy (due to pah1Delta) pathways of phospholipid biosynthesis. Unlike pah1Delta gat2Delta, neither the pah1Delta cho2Delta nor pah1Delta opi3Delta mutant exhibited improved growth (Fig. 9E) or nuclear membrane structure.4 Taken together, these data indicate that high PA levels are a major trigger for the nuclear membrane proliferation in yeast cells.
###end p 54
###begin p 55
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 8.</label>
###xml 9 107 9 107 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Overexpression of Dgk1p causes proliferation of the nuclear membrane but not cortical ER membrane.</bold>
###xml 107 108 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 155 159 155 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 200 204 200 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 234 238 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 239 241 239 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10</italic>
###xml 503 504 503 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 526 530 526 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HEH2</italic>
###xml 546 550 546 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 576 580 576 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 581 583 581 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10</italic>
###xml 726 738 726 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panels</italic>
###xml 768 780 768 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panels</italic>
###xml 851 852 851 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 874 878 874 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RTN2</italic>
###xml 894 898 894 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 924 928 924 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 929 931 929 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10</italic>
###xml 1054 1066 1054 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Upper panels</italic>
###xml 1077 1078 1077 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 1122 1134 1122 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panels</italic>
###xml 1191 1201 1191 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scale bars</italic>
###xml 9 1210 9 1209 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="56"><bold>Overexpression of Dgk1p causes proliferation of the nuclear membrane but not cortical ER membrane.</bold><italic>A</italic>, shown is the time course of the induction of <italic>DGK1</italic>-PtA. Wild-type cells (RS453) expressing <italic>DGK1</italic>-PtA under the control of the <italic>GAL1</italic>/<italic>10</italic> promoter in a centromeric plasmid were transferred from raffinose to galactose-containing medium, and protein extracts were prepared at the indicated time points. Protein samples were resolved by SDS-PAGE followed by Western blotting using anti-PtA antibodies. <italic>B</italic>, cells expressing an <italic>HEH2</italic>-GFP fusion and <italic>DGK1</italic> under the control of the <italic>GAL1</italic>/<italic>10</italic> promoter in a centromeric plasmid were transferred from raffinose to galactose-containing medium for the indicated times. Heh2p-GFP labeling (<italic>upper panels</italic>) or cell/Heh2p-GFP overlays (<italic>lower panels</italic>) were visualized at the indicated time points by confocal microscopy. <italic>C</italic>, cells expressing an <italic>RTN2</italic>-GFP fusion and <italic>DGK1</italic> under the control of the <italic>GAL1</italic>/<italic>10</italic> promoter in a centromeric plasmid were transferred from raffinose to galactose-containing medium for the indicated times. <italic>Upper panels</italic>, confocal <italic>Z</italic>-sections corresponding to the cell center; <italic>lower panels</italic>, confocal sections corresponding to the cell periphery. <italic>Scale bars</italic> = 5 &#956;m.</p>
###xml 9 1210 9 1209 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="56"><bold>Overexpression of Dgk1p causes proliferation of the nuclear membrane but not cortical ER membrane.</bold><italic>A</italic>, shown is the time course of the induction of <italic>DGK1</italic>-PtA. Wild-type cells (RS453) expressing <italic>DGK1</italic>-PtA under the control of the <italic>GAL1</italic>/<italic>10</italic> promoter in a centromeric plasmid were transferred from raffinose to galactose-containing medium, and protein extracts were prepared at the indicated time points. Protein samples were resolved by SDS-PAGE followed by Western blotting using anti-PtA antibodies. <italic>B</italic>, cells expressing an <italic>HEH2</italic>-GFP fusion and <italic>DGK1</italic> under the control of the <italic>GAL1</italic>/<italic>10</italic> promoter in a centromeric plasmid were transferred from raffinose to galactose-containing medium for the indicated times. Heh2p-GFP labeling (<italic>upper panels</italic>) or cell/Heh2p-GFP overlays (<italic>lower panels</italic>) were visualized at the indicated time points by confocal microscopy. <italic>C</italic>, cells expressing an <italic>RTN2</italic>-GFP fusion and <italic>DGK1</italic> under the control of the <italic>GAL1</italic>/<italic>10</italic> promoter in a centromeric plasmid were transferred from raffinose to galactose-containing medium for the indicated times. <italic>Upper panels</italic>, confocal <italic>Z</italic>-sections corresponding to the cell center; <italic>lower panels</italic>, confocal sections corresponding to the cell periphery. <italic>Scale bars</italic> = 5 &#956;m.</p></caption>
###xml 1210 1210 1209 1209 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0300842590008"/>
###xml 0 1210 0 1209 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig8"><label>FIGURE 8.</label><caption><p textid="56"><bold>Overexpression of Dgk1p causes proliferation of the nuclear membrane but not cortical ER membrane.</bold><italic>A</italic>, shown is the time course of the induction of <italic>DGK1</italic>-PtA. Wild-type cells (RS453) expressing <italic>DGK1</italic>-PtA under the control of the <italic>GAL1</italic>/<italic>10</italic> promoter in a centromeric plasmid were transferred from raffinose to galactose-containing medium, and protein extracts were prepared at the indicated time points. Protein samples were resolved by SDS-PAGE followed by Western blotting using anti-PtA antibodies. <italic>B</italic>, cells expressing an <italic>HEH2</italic>-GFP fusion and <italic>DGK1</italic> under the control of the <italic>GAL1</italic>/<italic>10</italic> promoter in a centromeric plasmid were transferred from raffinose to galactose-containing medium for the indicated times. Heh2p-GFP labeling (<italic>upper panels</italic>) or cell/Heh2p-GFP overlays (<italic>lower panels</italic>) were visualized at the indicated time points by confocal microscopy. <italic>C</italic>, cells expressing an <italic>RTN2</italic>-GFP fusion and <italic>DGK1</italic> under the control of the <italic>GAL1</italic>/<italic>10</italic> promoter in a centromeric plasmid were transferred from raffinose to galactose-containing medium for the indicated times. <italic>Upper panels</italic>, confocal <italic>Z</italic>-sections corresponding to the cell center; <italic>lower panels</italic>, confocal sections corresponding to the cell periphery. <italic>Scale bars</italic> = 5 &#956;m.</p></caption><graphic xlink:href="zbc0300842590008"/></fig>
FIGURE 8.Overexpression of Dgk1p causes proliferation of the nuclear membrane but not cortical ER membrane.A, shown is the time course of the induction of DGK1-PtA. Wild-type cells (RS453) expressing DGK1-PtA under the control of the GAL1/10 promoter in a centromeric plasmid were transferred from raffinose to galactose-containing medium, and protein extracts were prepared at the indicated time points. Protein samples were resolved by SDS-PAGE followed by Western blotting using anti-PtA antibodies. B, cells expressing an HEH2-GFP fusion and DGK1 under the control of the GAL1/10 promoter in a centromeric plasmid were transferred from raffinose to galactose-containing medium for the indicated times. Heh2p-GFP labeling (upper panels) or cell/Heh2p-GFP overlays (lower panels) were visualized at the indicated time points by confocal microscopy. C, cells expressing an RTN2-GFP fusion and DGK1 under the control of the GAL1/10 promoter in a centromeric plasmid were transferred from raffinose to galactose-containing medium for the indicated times. Upper panels, confocal Z-sections corresponding to the cell center; lower panels, confocal sections corresponding to the cell periphery. Scale bars = 5 mum.
###end p 55
###begin p 56
###xml 0 98 0 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Overexpression of Dgk1p causes proliferation of the nuclear membrane but not cortical ER membrane.</bold>
###xml 98 99 98 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 191 195 191 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 230 232 230 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10</italic>
###xml 494 495 494 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 517 521 517 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HEH2</italic>
###xml 537 541 537 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 567 571 567 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 572 574 572 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10</italic>
###xml 717 729 717 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panels</italic>
###xml 759 771 759 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panels</italic>
###xml 842 843 842 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 865 869 865 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RTN2</italic>
###xml 885 889 885 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 915 919 915 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 920 922 920 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink">10</italic>
###xml 1045 1057 1045 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Upper panels</italic>
###xml 1068 1069 1068 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 1113 1125 1113 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panels</italic>
###xml 1182 1192 1182 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scale bars</italic>
Overexpression of Dgk1p causes proliferation of the nuclear membrane but not cortical ER membrane.A, shown is the time course of the induction of DGK1-PtA. Wild-type cells (RS453) expressing DGK1-PtA under the control of the GAL1/10 promoter in a centromeric plasmid were transferred from raffinose to galactose-containing medium, and protein extracts were prepared at the indicated time points. Protein samples were resolved by SDS-PAGE followed by Western blotting using anti-PtA antibodies. B, cells expressing an HEH2-GFP fusion and DGK1 under the control of the GAL1/10 promoter in a centromeric plasmid were transferred from raffinose to galactose-containing medium for the indicated times. Heh2p-GFP labeling (upper panels) or cell/Heh2p-GFP overlays (lower panels) were visualized at the indicated time points by confocal microscopy. C, cells expressing an RTN2-GFP fusion and DGK1 under the control of the GAL1/10 promoter in a centromeric plasmid were transferred from raffinose to galactose-containing medium for the indicated times. Upper panels, confocal Z-sections corresponding to the cell center; lower panels, confocal sections corresponding to the cell periphery. Scale bars = 5 mum.
###end p 56
###begin title 57
DISCUSSION
###end title 57
###begin p 58
###xml 175 180 <span type="species:ncbi:4932">yeast</span>
###xml 307 312 <span type="species:ncbi:4932">yeast</span>
How phospholipids impact on organelle structure remains largely unknown. In this work, we have shown that PA homeostasis is a critical factor controlling nuclear structure in yeast. In two genetic screens looking for novel regulators of PA metabolism, we identified Dgk1p, the first DAG kinase described in yeast. Dgk1p-driven overproduction of PA at the nuclear membrane causes nuclear expansion, without proliferating cortical ER membrane. Thus, the modulation of Dgk1p activity offers a unique model system to study the regulation of nuclear growth.
###end p 58
###begin p 59
###xml 0 41 0 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dgk1p Is a Novel CTP-dependent DAG Kinase</italic>
###xml 264 265 264 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 266 268 266 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XX</italic>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref33">33</xref>
###xml 621 622 621 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn5">4</xref>
###xml 957 961 957 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INO1</italic>
###xml 1001 1003 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
Dgk1p Is a Novel CTP-dependent DAG Kinase-DAG kinase enzymes have been identified in almost all organisms examined, including bacteria, plants, worms, flies, and mammals. All DAG kinases have a catalytic domain that contains an ATP-binding site with the sequence GXGXXG that is essential for the kinase reaction (22, 23). Dgk1p is an unconventional DAG kinase that uses CTP, instead of ATP, as a phosphate donor and therefore does not exhibit sequence similarity to DAG kinases from other species. Furthermore, Dgk1p contains a short motif recently identified in a family of CTP-dependent phytol and dolichol kinases (33)4. Although the significance of this difference between Dgk1p and the other DAG kinases is not yet clear, it could have important physiological implications. Previous studies have established that elevated levels of cytosolic CTP (due to a defect in CTP feedback inhibition of CTP synthase) lead to increased PA levels, derepression of INO1, and the inositol excretion phenotype (34). Our data raise the possibility that this regulation is mediated by the CTP-driven activation of Dgk1p.
###end p 59
###begin p 60
###xml 0 37 0 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Regulation of PA Homeostasis by Dgk1p</italic>
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAH1</italic>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 513 517 513 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DGK1</italic>
###xml 521 525 521 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
Regulation of PA Homeostasis by Dgk1p-The genetic interactions between DGK1 and PAH1 fit well with the biochemical data on the activity of Dgk1p. Overexpression of a hyperactive Pah1p mutant decreases cellular PA by converting it to DAG, causing the PA-dependent repression of phospholipid biosynthetic genes by Opi1p, and results in inositol auxotrophy (11). This lethality can be rescued by the overexpression of Dgk1p, which catalyzes the reverse reaction and restores PA levels. The fact that the deletion of DGK1 in pah1Delta cells returns PA levels to normal could indicate that, in wild-type cells, Dgk1p produces some of the ER pools of PA that are accessible to Pah1p.
###end p 60
###begin p 61
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 119 123 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 233 237 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dgk1</italic>
###xml 243 247 231 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 399 403 371 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 598 602 566 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
Although the dgk1Delta mutation returns the levels of the other abundant phospholipids, PC and PE, almost to normal in pah1Delta cells, it does not change the defects in phosphatidylinositol and triacylglycerol levels. The fact that dgk1Delta pah1Delta cells have completely normal nuclear structure but still exhibit growth defects at 30 degreesC and are temperature-sensitive at 37 degreesC, like pah1Delta cells, suggests that PA and/or PC and PE are responsible for the effects on the nuclear membrane, whereas phosphatidylinositol and triacylglycerol levels contribute more to the toxicity of pah1Delta cells.
###end p 61
###begin p 62
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 232 234 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 242 246 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gat2</italic>
###xml 277 281 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 378 380 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 587 591 575 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gat1</italic>
###xml 601 605 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gat2</italic>
###xml 658 660 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 716 720 696 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
Interestingly, not all enzymes involved in the production of PA can rescue pah1Delta when removed. Although deletion of either Gat1p or Gat2p ER acyltransferases has been shown previously to significantly reduce cellular PA levels (31), only gat2Delta can partially rescue the pah1Delta defects. The fact that these two enzymes have distinct fatty acyl substrate specificities (31) raises the intriguing possibility that different PA pools, with respect to acyl chain length and/or saturation, could have different physiological effects. Alternatively, differences in the effects of the gat1Delta and gat2Delta mutations in lipid synthesis downstream of PA (35) could also contribute to their differential rescue of pah1Delta cells.
###end p 62
###begin p 63
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 9.</label>
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 9 76 9 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Genetic interactions of phospholipid biosynthetic mutants with <italic>pah1</italic></bold>
###xml 82 139 78 135 <bold xmlns:xlink="http://www.w3.org/1999/xlink">indicate a role for PA in nuclear membrane proliferation.</bold>
###xml 139 140 135 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 154 158 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAT2</italic>
###xml 199 203 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 324 325 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 339 343 325 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAT2</italic>
###xml 354 358 340 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INO1</italic>
###xml 378 382 364 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 414 418 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INO1</italic>
###xml 584 588 566 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RTG2</italic>
###xml 780 781 762 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 787 791 769 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAT2</italic>
###xml 963 964 939 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 981 985 957 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAT2</italic>
###xml 1038 1042 1014 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1059 1063 1031 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1069 1073 1037 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gat2</italic>
###xml 1097 1102 1061 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 1200 1209 1164 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scale bar</italic>
###xml 1219 1220 1182 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1234 1238 1197 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PSD1</italic>
###xml 1240 1244 1203 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHO2</italic>
###xml 1250 1254 1213 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OPI3</italic>
###xml 1293 1297 1256 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1368 1378 1327 1337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 1404 1409 1363 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5-FOA</italic>
###xml 1411 1422 1370 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
###xml 9 1487 9 1440 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="64"><bold>Genetic interactions of phospholipid biosynthetic mutants with <italic>pah1</italic></bold>&#916; <bold>indicate a role for PA in nuclear membrane proliferation.</bold><italic>A</italic>, deletion of <italic>GAT2</italic> partially rescues the growth defects of <italic>pah1</italic>&#916;. Serial dilutions of the indicated strains were spotted on YEPD plates and grown for 2 days at 30 and 37 &#176;C. <italic>B</italic>, deletion of <italic>GAT2</italic> decreases <italic>INO1</italic> mRNA levels in the <italic>pah1</italic>&#916; cells. The mRNA levels of <italic>INO1</italic> were analyzed in the indicated strains grown in YEPD medium by quantitative real-time PCR. Amplification of each sample was performed in duplicate and normalized to <italic>RTG2</italic>. Values and errors were calculated from three independent experiments. The values indicated within the bars represent the -fold derepression over the values measured in the wild-type strain. <italic>C</italic>, the <italic>GAT2</italic>-dependent rescue depends on its catalytic activity. Serial dilutions of the indicated strains were spotted on synthetic plates and grown for 2 days at 30 and 37 &#176;C. <italic>D</italic>, lack of active <italic>GAT2</italic> partially rescues nuclear membrane proliferation in <italic>pah1</italic>&#916; cells. The <italic>pah1</italic>&#916; <italic>gat2</italic>&#916; mutant expressing <italic>SEC63</italic>-GFP was transformed with the indicated plasmids, and cells were observed by confocal microscopy. <italic>Scale bar</italic> = 5 &#956;m. <italic>E</italic>, deletion of <italic>PSD1</italic>, <italic>CHO2</italic>, and <italic>OPI3</italic> does not rescue the growth defects of <italic>pah1</italic>&#916;. Serial dilutions of the indicated strains were spotted on -URA (<italic>left panel</italic>) or 5-fluoroorotic acid (<italic>5-FOA</italic>; <italic>right panel</italic>) plates and grown for 2 or 3 days, respectively, at 30 &#176;C.</p>
###xml 9 1487 9 1440 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="64"><bold>Genetic interactions of phospholipid biosynthetic mutants with <italic>pah1</italic></bold>&#916; <bold>indicate a role for PA in nuclear membrane proliferation.</bold><italic>A</italic>, deletion of <italic>GAT2</italic> partially rescues the growth defects of <italic>pah1</italic>&#916;. Serial dilutions of the indicated strains were spotted on YEPD plates and grown for 2 days at 30 and 37 &#176;C. <italic>B</italic>, deletion of <italic>GAT2</italic> decreases <italic>INO1</italic> mRNA levels in the <italic>pah1</italic>&#916; cells. The mRNA levels of <italic>INO1</italic> were analyzed in the indicated strains grown in YEPD medium by quantitative real-time PCR. Amplification of each sample was performed in duplicate and normalized to <italic>RTG2</italic>. Values and errors were calculated from three independent experiments. The values indicated within the bars represent the -fold derepression over the values measured in the wild-type strain. <italic>C</italic>, the <italic>GAT2</italic>-dependent rescue depends on its catalytic activity. Serial dilutions of the indicated strains were spotted on synthetic plates and grown for 2 days at 30 and 37 &#176;C. <italic>D</italic>, lack of active <italic>GAT2</italic> partially rescues nuclear membrane proliferation in <italic>pah1</italic>&#916; cells. The <italic>pah1</italic>&#916; <italic>gat2</italic>&#916; mutant expressing <italic>SEC63</italic>-GFP was transformed with the indicated plasmids, and cells were observed by confocal microscopy. <italic>Scale bar</italic> = 5 &#956;m. <italic>E</italic>, deletion of <italic>PSD1</italic>, <italic>CHO2</italic>, and <italic>OPI3</italic> does not rescue the growth defects of <italic>pah1</italic>&#916;. Serial dilutions of the indicated strains were spotted on -URA (<italic>left panel</italic>) or 5-fluoroorotic acid (<italic>5-FOA</italic>; <italic>right panel</italic>) plates and grown for 2 or 3 days, respectively, at 30 &#176;C.</p></caption>
###xml 1487 1487 1440 1440 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0300842590009"/>
###xml 0 1487 0 1440 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig9"><label>FIGURE 9.</label><caption><p textid="64"><bold>Genetic interactions of phospholipid biosynthetic mutants with <italic>pah1</italic></bold>&#916; <bold>indicate a role for PA in nuclear membrane proliferation.</bold><italic>A</italic>, deletion of <italic>GAT2</italic> partially rescues the growth defects of <italic>pah1</italic>&#916;. Serial dilutions of the indicated strains were spotted on YEPD plates and grown for 2 days at 30 and 37 &#176;C. <italic>B</italic>, deletion of <italic>GAT2</italic> decreases <italic>INO1</italic> mRNA levels in the <italic>pah1</italic>&#916; cells. The mRNA levels of <italic>INO1</italic> were analyzed in the indicated strains grown in YEPD medium by quantitative real-time PCR. Amplification of each sample was performed in duplicate and normalized to <italic>RTG2</italic>. Values and errors were calculated from three independent experiments. The values indicated within the bars represent the -fold derepression over the values measured in the wild-type strain. <italic>C</italic>, the <italic>GAT2</italic>-dependent rescue depends on its catalytic activity. Serial dilutions of the indicated strains were spotted on synthetic plates and grown for 2 days at 30 and 37 &#176;C. <italic>D</italic>, lack of active <italic>GAT2</italic> partially rescues nuclear membrane proliferation in <italic>pah1</italic>&#916; cells. The <italic>pah1</italic>&#916; <italic>gat2</italic>&#916; mutant expressing <italic>SEC63</italic>-GFP was transformed with the indicated plasmids, and cells were observed by confocal microscopy. <italic>Scale bar</italic> = 5 &#956;m. <italic>E</italic>, deletion of <italic>PSD1</italic>, <italic>CHO2</italic>, and <italic>OPI3</italic> does not rescue the growth defects of <italic>pah1</italic>&#916;. Serial dilutions of the indicated strains were spotted on -URA (<italic>left panel</italic>) or 5-fluoroorotic acid (<italic>5-FOA</italic>; <italic>right panel</italic>) plates and grown for 2 or 3 days, respectively, at 30 &#176;C.</p></caption><graphic xlink:href="zbc0300842590009"/></fig>
FIGURE 9.Genetic interactions of phospholipid biosynthetic mutants with pah1Delta indicate a role for PA in nuclear membrane proliferation.A, deletion of GAT2 partially rescues the growth defects of pah1Delta. Serial dilutions of the indicated strains were spotted on YEPD plates and grown for 2 days at 30 and 37 degreesC. B, deletion of GAT2 decreases INO1 mRNA levels in the pah1Delta cells. The mRNA levels of INO1 were analyzed in the indicated strains grown in YEPD medium by quantitative real-time PCR. Amplification of each sample was performed in duplicate and normalized to RTG2. Values and errors were calculated from three independent experiments. The values indicated within the bars represent the -fold derepression over the values measured in the wild-type strain. C, the GAT2-dependent rescue depends on its catalytic activity. Serial dilutions of the indicated strains were spotted on synthetic plates and grown for 2 days at 30 and 37 degreesC. D, lack of active GAT2 partially rescues nuclear membrane proliferation in pah1Delta cells. The pah1Delta gat2Delta mutant expressing SEC63-GFP was transformed with the indicated plasmids, and cells were observed by confocal microscopy. Scale bar = 5 mum. E, deletion of PSD1, CHO2, and OPI3 does not rescue the growth defects of pah1Delta. Serial dilutions of the indicated strains were spotted on -URA (left panel) or 5-fluoroorotic acid (5-FOA; right panel) plates and grown for 2 or 3 days, respectively, at 30 degreesC.
###end p 63
###begin p 64
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Genetic interactions of phospholipid biosynthetic mutants with <italic>pah1</italic></bold>
###xml 73 130 69 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink">indicate a role for PA in nuclear membrane proliferation.</bold>
###xml 130 131 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 145 149 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAT2</italic>
###xml 190 194 186 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 315 316 301 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 330 334 316 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAT2</italic>
###xml 345 349 331 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INO1</italic>
###xml 369 373 355 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 405 409 387 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INO1</italic>
###xml 575 579 557 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RTG2</italic>
###xml 771 772 753 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 778 782 760 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAT2</italic>
###xml 954 955 930 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 972 976 948 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAT2</italic>
###xml 1029 1033 1005 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1050 1054 1022 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1060 1064 1028 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gat2</italic>
###xml 1088 1093 1052 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEC63</italic>
###xml 1191 1200 1155 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scale bar</italic>
###xml 1210 1211 1173 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1225 1229 1188 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PSD1</italic>
###xml 1231 1235 1194 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CHO2</italic>
###xml 1241 1245 1204 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OPI3</italic>
###xml 1284 1288 1247 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 1359 1369 1318 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 1395 1400 1354 1359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5-FOA</italic>
###xml 1402 1413 1361 1372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panel</italic>
Genetic interactions of phospholipid biosynthetic mutants with pah1Delta indicate a role for PA in nuclear membrane proliferation.A, deletion of GAT2 partially rescues the growth defects of pah1Delta. Serial dilutions of the indicated strains were spotted on YEPD plates and grown for 2 days at 30 and 37 degreesC. B, deletion of GAT2 decreases INO1 mRNA levels in the pah1Delta cells. The mRNA levels of INO1 were analyzed in the indicated strains grown in YEPD medium by quantitative real-time PCR. Amplification of each sample was performed in duplicate and normalized to RTG2. Values and errors were calculated from three independent experiments. The values indicated within the bars represent the -fold derepression over the values measured in the wild-type strain. C, the GAT2-dependent rescue depends on its catalytic activity. Serial dilutions of the indicated strains were spotted on synthetic plates and grown for 2 days at 30 and 37 degreesC. D, lack of active GAT2 partially rescues nuclear membrane proliferation in pah1Delta cells. The pah1Delta gat2Delta mutant expressing SEC63-GFP was transformed with the indicated plasmids, and cells were observed by confocal microscopy. Scale bar = 5 mum. E, deletion of PSD1, CHO2, and OPI3 does not rescue the growth defects of pah1Delta. Serial dilutions of the indicated strains were spotted on -URA (left panel) or 5-fluoroorotic acid (5-FOA; right panel) plates and grown for 2 or 3 days, respectively, at 30 degreesC.
###end p 64
###begin p 65
###xml 0 45 0 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A Role for PA Metabolism in Nuclear Structure</italic>
###xml 176 177 176 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink">5</sub>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37">37</xref>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37">37</xref>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
A Role for PA Metabolism in Nuclear Structure-Overexpression of certain transmembrane enzymes involved in lipid biosynthesis, such as hydroxymethylglutaryl-CoA and cytochrome b5, induces membrane biogenesis in the form of karmellae, stacks of proliferated ER wrapped around the nucleus (36, 37). In both cases, ER membrane proliferation could be induced even when the catalytically inactive proteins were overexpressed (37, 38), indicating that, unlike Dgk1p, membrane proliferation in these cells is not a direct consequence of changes in lipid composition but rather a response to accommodate the excess transmembrane proteins.
###end p 65
###begin p 66
###xml 348 349 348 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 342 349 342 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 514 518 514 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pah1</italic>
###xml 531 533 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 632 636 628 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OPI1</italic>
###xml 812 814 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 1371 1373 1363 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref39">39</xref>
###xml 1375 1377 1367 1369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref40">40</xref>
Here, we have shown that the DAG kinase activity of Dgk1p is responsible for nuclear membrane proliferation. High PA levels can have two distinct effects on lipid homeostasis and membrane biogenesis that could be responsible for nuclear growth. First, PA acts as a signal that derepresses transcription of key enzymes of the CDP-DAG pathway (Fig. 1A), which provide bulk phospholipids for membrane formation. Indeed, transcriptional derepression of these enzymes is necessary for nuclear membrane proliferation in pah1Delta cells (10). However, constitutive overexpression of the biosynthetic enzymes in cells lacking the repressor OPI1 does not lead to nuclear membrane expansion, suggesting that, apart from the derepression of lipid synthesis in the ER, other events contribute to nuclear membrane expansion (11). The second effect of PA on membranes is due to its conical structure and its bending functions that are implicated in many remodeling events like membrane budding and fission. Changes in the physical properties of the double bilayered nuclear membrane could contribute to its expansion. Interestingly, a role for membrane tubulation in nuclear membrane expansion has been described recently in tissue cultured cells in which expression of membrane-deforming mutants of CTP-phosphocholine cytidylyltransferase-alpha causes nuclear membrane proliferation (39, 40).
###end p 66
###begin p 67
###xml 514 519 <span type="species:ncbi:4932">yeast</span>
The distinct functions of Dgk1p-driven PA production in the nuclear envelope are also underscored by the fact that overproduction of Dgk1p does not appear to significantly induce cortical ER membrane proliferation, as visualized using a reticulon-GFP fusion. This raises the intriguing question of whether PA and downstream-derived phospholipids are differentially processed in the two subcompartments or whether active Dgk1p concentrates preferentially on the nuclear membrane. Given the significant changes that yeast nuclei undergo during cell division, the temporal and spatial regulation of PA metabolism by Dgk1p and Pah1p could play crucial roles in this process. Future studies will further address the role of Dgk1p in nuclear structure and phospholipid biosynthesis.
###end p 67
###begin title 68
Supplementary Material
###end title 68
###begin title 69
[Author Profile]
###end title 69
###begin p 70
We thank Dr. Aaron Neiman for plasmids and Drs. N. Ktistakis, F. Reggiori, and H. Santos-Rosa for comments on the manuscript.
###end p 70
###begin p 71
The abbreviations used are: ER, endoplasmic reticulum; PA, phosphatidate; DAG, diacylglycerol; GFP, green fluorescent protein; PE, phosphatidylethanolamine; PC, phosphatidylcholine; PtA, protein A; RFP, red fluorescent protein.
###end p 71
###begin p 72
S. Siniossoglou, unpublished data.
###end p 72

